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           Analysis of metazoan genomes has led to the extraordinary observation that mammals 
contain only ~25000 protein-coding genes. Therefore, post-transcriptional gene regulatory 
mechanisms (PTGRMs) are thought to be crucial for generating the diverse proteome required to 
support their high cellular complexity. Alternative splicing (AS), the most common PTGRM, is a 
process by which the exons of a pre-mRNA are spliced into different arrangements to produce 
structurally and functionally distinct mature mRNAs thereby contributing to the transcriptome 
complexity. Regulated AS events are known to play a determinative role in the brain, heart and 
skeletal muscle development; however, regulation of splicing or its function in hepatic growth 
and maturation is not well understood. 
           The mammalian liver is a major metabolic organ responsible for a variety of functions and 
has an exceptional capacity for regeneration. Liver undergoes dramatic transitions with regards 
to structure and function during postnatal development and during regeneration implying that 
intricate regulatory mechanisms must control these processes.  Signaling and transcriptional 
networks that regulate postnatal liver development are extensively studied, but the role of post-
transcriptional mechanisms is poorly explored. My goal thus was to identify conserved AS 
networks in postnatal liver development and establish relationships between these splicing 
changes and their putative regulators, RNA Binding proteins, in normal liver maturation and 
regeneration. 
            In the second chapter of the thesis, I studied the changes occurring in the liver 
transcriptome during postnatal periods of development.  To characterize the conserved AS 
program during mammalian liver maturation, high throughput RNA-seq of mouse livers at E18 
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(embryonic day 18), P14 (postnatal day 14), P28 and P90 was performed. We observed ~5000 
genes change in mRNA abundance, ~530 genes change in AS and ~200 genes change in 
alternative polyadenylation with minimal overlap among these categories. This indicates that 
postnatal liver maturation is accomplished by three separate modes of regulatory mechanisms. 
Analysis of AS at intervening timepoints (E16, E18, P0, P2, P7, P14, P28 and P90) showed that 
postnatal shift in AS is temporally coordinated and subsets of AS events follow distinct patterns 
of splicing change grouped as early (E16-P2), late (P14-P90) or biphasic (E18-P7 and P7-P90). 
As the liver is actively going through the process of maturation, we wanted to understand 
whether the changes occurring in the transcriptome are a result of the maturing parenchyma or 
due to a cell population change occurring in the liver. Comparison of AS in purified hepatocytes 
(Hep), major cell type of the liver, and the other cell types, non-parenchymal cells (NPCs) 
showed that a majority of AS are cell-type specific with most being Hep-specific. These AS 
transitions are evolutionarily conserved in mice and humans.   
            RNA binding proteins (RBPs) play pivotal roles in regulating splicing transitions by 
binding near the variably used splice sites and modulating their accessibility to the spliceosome. 
Thus, using our RNA-sequencing data, we analyzed the expression of RBPs and found that the 
majority are down regulated at both mRNA and protein levels during postnatal liver maturation. 
The expression of these RBPs also follows distinct temporal patterns overlapping with subsets of 
AS transitions. The remarkable exception is ESRP2 (Epithelial Splicing Regulatory Protein 2), 
which is strongly upregulated postnatally. Mammalian ESRP2 belongs to a family of tissue-
specific AS regulators, which are essential regulators that drive mesenchymal to epithelial 
transition by coordinating splicing of genes involved in cell-cell adhesion, cytoskeleton 
rearrangement, and intracellular signaling. 
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              The third chapter describes the studies done to establish that ESRP2 is a key regulator of 
postnatal splicing in maturing hepatocytes. ESRP2 was the only factor that exhibited significant 
up regulation in mRNA and protein levels during the first four weeks after birth. Upon assaying 
its relative mRNA and protein levels in purified Hep and NPC fractions from P0 and adult mouse 
livers, I found that ESRP2 levels are specifically higher in adult Hep. To ascertain whether 
ESRP2 plays a crucial role in fetal-to-adult shift of AS in liver, I obtained liver tissue from 
ESRP2 knock-out mice (ERSP2 KO) generated using full gene deletion and performed splicing 
analysis of 141 developmentally regulated AS events. I found that 31 AS events were strongly 
misspliced and showed a failure of fetal-to-adult splicing switch indicating that ESRP2 regulates 
these events during normal development. To investigate whether ESRP2 expression is sufficient 
for the fetal-to-adult switch of the AS transitions, I over expressed ESRP2 protein in liver cell 
lines HepG2 and AML12, using an adenoviral vector. These cell lines have minimal expression 
of ESRP2 and exhibit a neonatal splicing pattern. Forced expression of ESRP2 causes a fetal-to-
adult splicing switch in the majority of these 31 targets, reinforcing the role of ESRP2. When 
evaluated for cell-type specificity, I found that 87% of ESRP2 targets were Hep-specific events. 
ESRP2 KO livers also showed a loss of mature hepatocyte markers like Cyp2b10, Alb and Chd1 
and a persistent expression of fetal genes like Meg3 and Chd2. Histological analysis showed that 
ESRP2 KOs have a normal hepato-somatic index, but have smaller cells with increased number 
of mono- and bi-nucleated hepatocytes. Based on these results, I conclude that ESRP2 is a key 
regulator of post-natal splicing program in maturing hepatocytes. 
                In chapter four, I describe the details of the project I initiated to characterize the AS 
program during liver regeneration. I used DDC (3, 5-diethoxycarbonyl-1, 4-dihydrocollidine), a 
hepatotoxin, to induce liver regeneration in mice. This established model of liver regeneration 
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closely mimics the normal route through which liver regenerates in response to toxins. To 
characterize the AS program during liver regeneration, we performed RNA-seq of mouse livers 
which were treated with DDC for four weeks and mice which were on normal chow diet. The 
RNA-Seq data showed that ~3000 genes change in mRNA abundance and ~230 events change in 
AS upon toxin injury with minimal overlap. As the regenerating liver, has actively proliferating 
hepatocytes, it is plausible to have similar characteristics of an immature liver. Therefore, upon 
comparing the data set of developmentally regulated AS events with the list of genes that are 
differentially spliced in regeneration we find that there is a large subset of AS events common to 
both. These common AS transitions show splicing in reciprocal direction for development and 
regeneration, indicating that during regeneration these AS events exhibit a neonatal splicing 
pattern.  
               To gain mechanistic information of the regulatory networks governing liver 
regeneration, it is necessary to look at the roles of RBPs. Our analysis has shown that many 
RBPs that are strongly down regulated during normal liver development are upregulated in 
regenerating livers. These RBPs exhibit similar expression in Hep isolated from livers treated 
with DDC indicating that these factors may play a role in governing the AS landscape during 
regeneration. Interestingly, I observed that ESRP2 mRNA and protein levels were 
downregulated in livers and hepatocytes treated with DDC for four weeks. Importantly, the 
expression levels of ESRP2 are restored in livers of animals that have been allowed to recover 
from the DDC treatment. Further studies should delineate the biological role of ESRP2 in 
controlling AS networks during liver regeneration. 
              In chapter five, I lay out the future directions to take this research forward. One 
observation we had while performing RNA-Seq for four week DDC treated livers, was that these 
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livers had massive inflammation and bile deposits due to the toxin-mediated injury. Therefore, it 
is probable that this RNA-Seq did not capture purely regeneration-based transcriptome changes, 
but also due to cell population change. One way to rectify this is to perform RNA-Seq on Hep 
isolated from DDC treated livers to avoid the background of the inflammatory cells. Another 
important area of research to develop is carefully characterizing the role of ESRP2 during 
mammalian liver regeneration. This is being undertaken by challenging ESRP2 KO and over 
expression mouse models with DDC to determine how gain and loss of ESRP2 expression 
affects the process of liver regeneration.  
              In conclusion, I have identified a conserved, cell-type specific and temporally 
coordinated AS program operative postnatal liver development and demonstrated a direct role for 
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CHAPTER ONE: INTRODUCTION 
The liver is the largest internal organ, responsible for myriad metabolic functions in the body like 
blood detoxification, regulation of cholesterol synthesis; and transport, glycolytic; and urea 
metabolism as well as; secretion of clotting factors, and serum proteins(Si-Tayeb et al., 2010). 
The liver undergoes striking alterations with respect to structure and function throughout the 
course of embryonic development. The adult liver comprises hepatocytes, the principal 
functional cell type of the liver, biliary epithelial cells (BECs), Kupffer cells, hepatic stellate 
cells and; sinusoidal endothelial cells. The mature liver functions seamlessly due the interactions 
and coordination of these cell types. During development, this concerted regulation is brought 
about by networks of transcriptional activators and co-factors like HNF4α, GATA4, FOXA to 
name a few, which have been studied extensively(Costa et al., 2003; Kyrmizi et al., 2006). 
Substantial research in the past two decades has led to a better understanding of how signaling 
pathways, transcription factors, and cell movements drive the process of hepatic development. 
These advances have also led to a deeper understanding of the fundamental mechanisms by 
which organogenesis is orchestrated in general. Thus, the landscape of regulation of liver 
development is well understood in terms of signaling and transcriptional pathways. 
 The major challenge is now to decipher exactly how these regulatory pathways are fine-tuned in 
a temporal manner to direct the liver to carry out its functions. The liver takes on the metabolic 
role early on in development and thus must respond to various long term (signals related to 
development and maturation), cyclic (circadian clock) or instantaneous cues (nutrient or 
xenobiotic cues). The emerging notion in the field is that regulation at the posttranscriptional 
level is responsible for modulating these cellular responses in the liver. Extensive research shows 





carrying the coding information from DNA in the nucleus to the ribosomes in the cytoplasm for 
translation. mRNAs undergo widespread remodeling by an assorted set of processing events like 
capping, splicing, polyadenylation, export, turnover, RNA editing, storage, etc.(Blencowe, 2006; 
Gerstberger et al., 2014; Kalsotra and Cooper, 2011). These are collectively termed as post-
transcriptional gene regulatory mechanisms (PTGRM). These regulatory mechanisms give an 
additional layer of regulation to the tissue to modify cellular responses in a temporal manner 
while giving rise to expanded proteome diversity. Major regulation of these transcriptomic 
changes is governed by RNA Binding Proteins (RBPs) in a tissue and cell type specific 
manner(Black, 2003; Wang et al., 2012; Yang et al., 2014). PTGRM has emerged as a powerful 
regulatory method for development and function in tissues like brain(Boutz et al., 2007; Li et al., 
2014; Quesnel-vallières et al., 2015), heart(Kalsotra et al., 2008, 2010), skeletal muscle(Boutz et 
al., 2007; Yang et al., 2014) but it has not been well studied in the context of the mammalian 
liver.  
BRIEF OVERVIEW OF LIVER ARCHITECTURE AND DEVELOPMENT: 
To understand how the liver performs its metabolic functions and how these functions are 
regulated, it is necessary to first understand the architecture and composition of the liver and its 
development process. The basic functional unit of the liver is called a lobule. It consists of 
repeated roughly hexagonal arrangements of plates of hepatocytes lined by sinusoidal capillaries 
radiating toward a central vein and consisting the portal triad (branches of the portal vein, hepatic 
artery and bile duct bundled together) at the peripheral corners. Hepatocytes are the major 
functional cell type of the liver, making up ~70% of the liver mass in an adult liver. Hepatocytes 
are cuboidal, polarized epithelial cells that carry out the major functions of the liver like 





detoxification, etc. The other non-parenchymal predominant cell types of the liver are 
cholangiocytes (Biliary Epithelial Cells, lining the bile ducts), sinusoidal endothelial cells, 
Kupffer cells and hepatic stellate cells. Although hepatocytes are the functional cell of the liver, 
there is growing research showing that these non-parenchymal cells (NPCs) have a direct impact 
on the development of hepatocytes as well as in coordinating proper hepatocyte 
function(Gressner et al., 1993; Kimura and Robertson, 2001; Lammert et al., 2003). 
Liver organogenesis and development has been extensively studied and is described in great 
details in several reviews(Gordillo et al., 2015; Lemaigre, 2009; Zaret, 2002; Zhao and Duncan, 
2005; Zorn et al., 2008). Here, we offer a very brief overview of the liver development and the 
main players coordinating it. The process of liver bud formation is well conserved across 
vertebrate species. The foregut endoderm in mammalian embryos gives rise to the liver along 
with other ventral organs like stomach, lungs, pancreas. The liver bud consists of hepatic 
endoderm cells, called hepatoblasts, which express several hepatic markers like alpha-fetoprotein 
transcripts and also transcription factors like GATA 4/6, FOXA2, HNF1β, and HNF4α(Bossard 
and Zaret, 1998; Lee et al., 2005; Lokmane et al., 2008). These bipotentiate hepatoblasts are the 
common precursor for hepatocytes as well as bile duct cells undergoing proliferation and 
differentiation to form the liver bud(Zaret, 2001). The hepatic bud formation and expansion of 
the liver requires the activation of a network of signaling pathways that coordinate proliferation, 
migration, intracellular adhesion and differentiation of hepatoblasts. Studies have shown that 
HEX, GATA 4/6 promote hepatoblast proliferation and differentiation(Bort et al., 2006; Zhao et 
al., 2005). These transcription factors along with HNF-6, ONECUT-2, T-box transcription factor 
3 and Prospero-related homeobox 1 are involved in cell migration and adhesion(Christoffels et 





liver is also the transient site for hematopoiesis, with the hematopoietic cells migrating to the 
adult bone marrow soon after birth.  The subsequent maturation of hepatocytes which starts in 
the embryonic stage continues postnatally. The hepatocytes begin expressing many new genes in 
the perinatal phase. Transcription factors like C/EBPα and HNF4 control the expression of these 
genes by regulating components of WNT/beta-catenin pathways. 
BRIEF OVERVIEW OF ALTERNATIVE SPLICING AND ROLE OF RNA BINDING 
PROTEINS: 
Mechanism of Splicing 
Every precursor mRNA (pre-mRNA) transcript of a protein coding gene undergoes a basal level 
of processing: 5’capping, constitutive splicing and 3’ polyA tail addition. The components 
required for these RNA processing steps can be separated into two categories: cis-acting factors 
and trans-acting elements. The cis-acting elements are sequence motifs positioned at specific 
locations in the mRNA, that direct the processing machinery for intron removal or generating the 
mRNA 3’ends(Fu and Ares  Jr., 2014). The trans-acting factors are the RNA-binding proteins 
that influence splicing by helping the recognition of exons.  
Splicing of pre-mRNA transcripts involves a 2-step process of sequential removal of the non-
coding introns from the exons by the spliceosome, a massive molecular machine consisting of 
small nuclear ribonucleoproteins (snRNPs), producing mature mRNA that can be used as a 
template for translation. In the first step, the pre-mRNA is cleaved at the 5’ splice site which has 
the base sequence of GU by the attack of the conserved Adenine residue of the branch point 





of splicing consists of the nucleophilic attack of the free 5’ exon on the 3’ splice site, where the 
base sequence is AG. The two exons are then joined together with the intron being released. 
Alternative Splicing 
In addition to these basal RNA processing steps, the pre-mRNA transcripts can also undergo 
Alternative Splicing (AS) and differential selection of polyadenylation sites. AS is a process by 
which the exons of pre-mRNAs are spliced into different arrangements to produce structurally 
and functionally distinct mature RNA (mRNA) isoforms contributing to transcriptome 
complexity(Blencowe, 2006). Thus, more than one mRNA and therefore, varied protein products 
can be generated from a single gene generating proteome diversity. Recent analyses based on 
deep sequencing data indicate that greater than 95% of human genes are alternatively spliced in 
some fashion(Wang et al., 2008). This differential splicing of exons leads to many possible types 
of AS events: exon skipping events (a cassette exon is spliced out); alternative 5’ and 3’ splice 
site selection (occurs when two or more splice sites are recognized at the ends of the exons); 
intron retention (an intron is retained in the mature RNA transcript); mutually exclusive exons 
(here one of the two exons are spliced out, but not both)(Keren et al., 2010). The exon skipping 
splicing events are the most common followed by the alternative 5’ and 3’ splice site 
selections(Pan et al., 2008). In addition to these, there are two other less frequent types of events: 
alternative promoter usage and alternative polyadenylation.  
The role of RNA Binding Proteins 
RNA binding proteins (RBPs) play pivotal roles in regulating splicing transitions by binding in 
cis near the variably used splice sites and modulating their accessibility to the 





to take a genome-wide look at the RBP targets as well as their protein partners. RBPs are 
involved in various aspects of mRNA regulation like maturation, stability, transport, and 
degradation. RBPs regulate the process of AS by positively or negatively influencing the 
inclusion or exclusion of exons.  
There are various classes of these splicing factors, which are expressed either ubiquitously or in a 
cell-type specific manner. The best known and well-studied examples are serine/arginine (SR) 
proteins and heterogenous nuclear ribonucleoproteins (hnRNPs)(Fu and Ares  Jr., 2014). 
However, RBPs also work in cell-type and tissue specific manner to coordinate the development 
and function of these tissues(Gerstberger et al., 2014; Kalsotra et al., 2008; Ule et al., 2005). In 
this project, we have studied the role of an RBP named ESRP2 (Epithelial Splicing Regulatory 
Protein 2), which is found to be specifically upregulated in maturing hepatocytes. 
ESRP Proteins 
ESRP proteins, ESRP1 and ESRP2, belong to a family of proteins which are cell-type specific 
regulators of transcripts that are essential for mesenchymal-to-epithelial transitions (MET). 
ESRPs have been shown to regulate the splicing of Fgfr2, as well as various other transcripts that 
have epithelial-specific splice variants(Warzecha et al., 2009, 2010). Recent studies have also 
shown that ESRP KO mice have severe defects in craniofacial development and are required for 
proper development of various organs like lungs, salivary gland, kidney as well as 
epidermis(Bebee et al., 2015). Thus, this points to the important role that ESRP proteins play in 
maintaining the epithelial fate of cells. ESRP1 is predominantly expressed in tissues like 
epidermis, small intestine, large intestine, salivary gland, etc. But we discovered that ESRP2 is 





nearly absent. Therefore, I decided to look closely at the role of ESRP2 protein in regulating 
developmentally regulated AS transitions during post-natal liver maturation.  
In this thesis, I have defined a conserved, cell-type specific and temporally coordinated AS 
program during postnatal liver development and demonstrated a direct role for ESRP2 in 
supporting a splicing regulatory network to support postnatal hepatocyte maturation. I will 
describe the role of ERSP2-mediated alternative splicing to help synchronize the process of post-
natal liver maturation temporally and highlight why deeper study in this layer of regulatory 
mechanisms is crucial for the further understanding of hepatic biology specifically, and how 






CHAPTER TWO: TRANSCRIPTOME REMODELING DURING LIVER 




Little is known about the changes occurring in the liver transcriptome during postnatal periods of 
development. Therefore, we performed a high-throughput RNA-Seq of mouse livers at E18 
(embryonic day 18), P14 (postnatal day 14), P28 and P90 to characterize the role of AS in 
mammalian liver maturation. We observed large-scale transcriptional and post-transcriptional 
changes during postnatal liver maturation. Analysis of AS shows an evolutionarily conserved, 
temporally co-regulated and cell-type specific postnatal shift in splicing during liver 
development. Detailed analysis at intervening timepoints (E16, E18, P0, P2, P7, P14, P28 and 
P90) showed subsets of AS events follow distinct patterns of splicing change grouped as early 
(E16-P2), late (P14-P90) or biphasic (E18-P7 and P7-P90). Furthermore, we discovered that 
majority of RBPs tested are downregulated during postnatal maturation, and the expression of 
these RBPs also follows distinct temporal patterns overlapping with subsets of AS transitions. 
Remarkably, only ESRP2 mRNA and protein expression showed an increase during liver 
maturation. 
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Mammalian tissues initially form and begin functioning in the embryo but are extensively 
remodeled after birth to rapidly adapt and perform adult functions. This process is especially true 
for the liver, which is hematopoietic in the embryo but converts into a major metabolic tissue in 
the adult(Si-Tayeb et al., 2010). Hepatocytes, which are highly proliferative in the fetus, become 
quiescent, undergo hypertrophic growth, and mature via large-scale changes in gene expression 
to maintain metabolic homeostasis during the dramatic transitions that occur during and after 
birth. Diverse genetic mechanisms ensure that these changes occur precisely and coordinately to 
initiate proper lineage specification, cell growth, and differentiation(Zaret, 2008). Most gene 
regulation studies in the liver have focused on transcriptional control(Costa et al., 2003; Kyrmizi 
et al., 2006); however, it is becoming clear that post-transcriptional mechanisms such as 
alternative pre-mRNA splicing (AS) have essential roles in sequential replacement of fetal-to-
adult protein isoforms(Elizalde et al., 2014; Pihlajamäki et al., 2011; Salati et al., 2004; Sen et 
al., 2013).  
AS allows multiple mRNAs with potentially different functions to be produced from a single 
gene(Lee and Rio, 2015; Nilsen and Graveley, 2010). Several estimates indicate that >95% of 
human multi-exon genes are alternatively spliced(Pan et al., 2008; Wang et al., 2008) and that 
most are extensively regulated in response to physiological needs(Kalsotra and Cooper, 2011). 
Such exquisite control is exerted through multiple RNA-binding proteins that bind to ‘core’ and 
‘auxiliary’ elements on pre-mRNAs to influence assembly of the basal splicing machinery near 
the 5’ and 3’ splice sites(Barash et al., 2010; Black, 2003; Fu and Ares  Jr., 2014; Licatalosi and 
Darnell, 2010; Matlin et al., 2005). The key splicing regulators that orchestrate tissue-specific 





2014; Quesnel-vallières et al., 2015; Ule et al., 2005), heart(Feng et al., 2009; Giudice et al., 
2014; Guo et al., 2012; Kalsotra et al., 2008, 2010; Wei et al.; Xu et al., 2005), skeletal muscle 
development(Boutz and Chawla, 2007; Hall et al., 2013; Lin, 2006; Singh et al., 2014; Yang et 
al., 2014), or T-cell activation(Mallory et al., 2015; Oberdoerffer et al., 2008) are well 
characterized; however, neither the full extent of transcript diversity nor the regulatory factors 
that drive isoform transitions in liver development are known.  
Here, using high-throughput RNA-sequencing, we characterize the transcriptome changes 
occurring in a maturing liver.  
MATERIALS AND METHODS: 
Animal Models and Human Samples 
Livers, non-parenchymal cells, and hepatocytes at specified timepoints were isolated from 
FVB/N wild-type mice. We followed the NIH guidelines for use and care of laboratory animals, 
and all experimental protocols were approved by IACUC (Institutional Animal Care and Use 
Committee at University of Illinois, Urbana-Champaign and University of Pennsylvania). Whole 
liver tissues, hepatocytes, and nonparenchymal cells were isolated from FVB/N mice post-natal 
day 0 (P0) and adult stage (3 months) for protein and RNA isolation. All animals used in this 
study, except P0 pups, were ear tagged and given specific identification numbers. Only ear tag 
numbers were used to identify the individual animals at the time of performing histological 
studies, serum biochemistry and liver function tests to keep the study double-blinded. The 
animals were grouped as WT or Esrp2 KO, without randomization, as per their genotyping 





specific and includes both male and female mice. Human fetal (22-week-old) and adult (51-year-
old Caucasian male) liver RNAs were purchased from Clonetech Laboratories, Inc. 
RNA-seq analysis 
Total liver RNAs from different developmental stages of wildtype (FVB/N) mice were isolated 
using RNeasy tissue mini-kit (QIAGEN). RNA quality was measured using an Agilent 
Bioanalyzer, and RNA was quantified using Qubit Fluorometer (Life Technologies) before 
library generation. Hi-Seq libraries were prepared, and paired-end 100bp Illumina sequencing 
was performed by the Genomic and RNA Profiling Core (GARP) at Baylor College of Medicine 
as previously described(Singh et al., 2014). RNA-Seq reads were aligned to mouse genome and 
transcriptome using a previously described method(Bahn et al., 2012; Li et al., 2012). Mapping 
percentage and details of each of the samples are shown in Supplementary Table 1. Gene 
expression levels were determined using RPKM (Reads Per Kilobase of transcript per Million 
mapped reads). Genes with significant expression difference between two groups of samples 
(FDR<0.1) was determined using DESeq(Anders and Huber, 2010). Differential splicing events 
between two groups of samples were identified using MATS (FDR ≤ 0.1, ΔPSI ≥ 15%) (Shen et 
al., 2012). To identify significantly different 3' UTR usage between two groups (FDR<0.1), core 
and extension regions of tandem 3' UTRs were identified based on RefSeq annotations, and P 
values were calculated using the numbers of reads mapped to the core and extension regions of 
two groups using Fisher's Exact test. A minimum read coverage of 5 was required. 
Accession Codes 






Gene Ontology (GO) and Pathway analysis 
Gene ontology analysis was performed using DAVID as previously described (Huang et al., 
2008). Mouse reference genome was used, and three Gene Ontology terms were used (BP, CC, 
and MF) and three Pathways were used (Biocarta, Kegg, and Panther) for the analysis.  
Functional Annotation Clustering was performed and the top clusters (Enrichment score = p-
value < .05) were summarized. A list of sequence specific, mouse DNA and RNA binding 
proteins were downloaded from the AmiGO2 database. Genes were then cross- referenced with 
the RNA-Seq data to determine those changing >3 fold in expression during mouse liver 
development. 
Isolation of Adult Hepatocytes and non-parenchymal cells 
Hep and NPC fractions were isolated with modifications of previously described methods(Li et 
al., 2010). Briefly, male adult FVB/N wild-type mice were perfused with 50 ml of Solution A 
(0.5 M EDTA in 1X Hanks Balanced Salt Solution without Ca2+ & Mg2+). Following this, the 
livers were perfused using 50 ml of Solution B (3000U of Collagenase Type I from Worthington, 
0.54 M CaCl2 and 40 mg/ml soybean trypsin inhibitor in 1X Hanks Balanced Salt Solution with 
Ca2+ & Mg2+). The perfused liver was removed in a petri dish containing 1X PBS, and cell 
scrapers were used to remove loose cells. The crude cell prep was filtered through 100 mm mesh 
filter, and the resulting cell suspension was centrifuged at 50 X g for 5 minutes. The Hep pellet 
was further washed with 1X PBS twice. The NPCs, which are in the supernatant, were isolated 







Isolation of P0 Hepatocytes and non-parenchymal cells 
The P0 livers were collected from FVB/N wild-type pups (males and females) and minced in 
Solution A. The tissue fragments were then agitated in Solution A at 37°C for 20 minutes. The 
supernatant was discarded, and the minced tissue was now digested using Solution B for 30 
minutes at 37°C. The resulting crude liver preparation was filtered using 100 mm mesh filter. 
The resulting cell suspension was processed as above for obtaining Hep and NPC fractions. 
Purified cell fractions from P0 and adult stage were subsequently lysed to extract protein or RNA 
using standard procedures. 
Protein isolation and Western blot analysis 
Proteins were isolated by homogenizing frozen liver tissue or purified cell fractions with cold 
homogenization buffer, 400 mL per 100 mg liver tissue [HEPES-KOH, pH 7.5, 10 mM, Sucrose 
0.32 M, MG132 5 μM, EDTA 5 mM, Proteinase inhibitor (1/2 tablet per 10 mL buffer)]. 
Samples were sonicated and clarified by centrifugation and protein content measured using BCA 
protein assay kit (Thermo Scientific). 40-60 μg proteins were resolved on 10% SDS-PAGE gels 
and transferred onto PVDF membranes (Immobilon, Millipore). Membranes were blocked in 
Tris-buffered saline (TBS) containing 10% nonfat dry milk and 0.1% Tween 20 (TBST), prior to 
incubation with primary antibody (0.5-2 mg/mL dilution) overnight at 4°C. The membranes were 
then washed with TBST followed by incubation with an appropriate horseradish peroxidase-
conjugated secondary antibody for two hours. The immunoreactivity was visualized on 
ChemiDoc XRS+ using the Clarity Western ECL kit (BioRad). HRP-conjugated rabbit 
monoclonal anti-ESRP1/2 (78 kDa; Rockland, 23A7.C9), mouse monoclonal anti-TBP (38 kDa; 
Pierce, 51841), mouse monoclonal anti-SRSF1 (27 kDa; ThermoFisher Scientific, 32-4600), 





(41 kDa; Milipore, 04-1469), mouse monoclonal anti-hnRNAP L (64 kDa; Abcam, ab6106), 
rabbit polyclonal anti-hnRNP LL (61 kDa; Cell Signaling, 4783S) rabbit polyclonal anti-
RBFOX2 (47 kDa; Bethyl, A300-864A), mouse monoclonal anti-CELF1 (52 kDa; Santa Cruz, 
SC20003), mouse monoclonal anti-PTBP1 (57 kDa; ThermoFisher Scientific, 32-4800), rabbit 
polyclonal anti-C/EBP1 (43 kDa; ThermoFisher Scientific, PA5-26487), chicken polyclonal anti-
albumin (66 kDa; Abcam, Ab106582),  MBNL2 (40 kDa; gift from T. Cooper), goat polyclonal 
anti-Gapdh (36 kDa; Santa Cruz, 20357) and goat polyclonal anti-β-actin (40 kDa; Santa Cruz, 
SC1616) were used. HRP-conjugated goat anti-mouse IgG light chain-specific (BioRad, 
1706516), goat anti-rabbit IgG (Thermo, 31460), rabbit anti-goat IgG (Santa Cruz, sc-2922) and 
rabbit anti-chicken IgY (Pierce, 31401) secondary antibodies were used at 1:2000 to 1:5000 
dilutions. 
Gene expression and splice isoform analysis 
Total RNAs were isolated from mouse livers or purified cell fractions using TRIzol reagent. 
Upon DNAse treatment (Promega), RNAs (~5 μg) were reverse transcribed using random 
hexamer primers and Maxima Reverse Transcriptase kit (Thermo Scientific). The cDNA was 
diluted to 25 ng/uL with nuclease free water and used for alternative splicing or qRT-PCR assays 
as previously described(Kalsotra et al., 2008). PSI (Percent Spliced In) values for the variably 
spliced region were calculated with ImageLab software (BioRad) as [(exon inclusion band 
intensity)/ (exon inclusion band intensity + exon exclusion band intensity) x 100]. qRT-PCR was 
performed in triplicate using 50 ng of cDNA per reaction on an Eco Real-Time PCR system 
(Illumina) using PerfeCTa SYBR Green FastMix (Quanta). An initial activation step for 10 





Details of the primer sequences can be found in Supplementary Table 2. Fold change of the 
mRNA was calculated as previously described(Kalsotra et al., 2008). 
RESULTS: 
Extensive transcriptome remodeling during liver maturation. 
To identify global changes in the liver transcriptome during postnatal development, we 
performed a high-resolution RNA-Seq analysis on poly (A)-selected RNA in biological 
duplicates from four developmental time points in the mouse liver: embryonic day (E)18, 
postnatal day (P)14, P28, and adult. We obtained an average of 200 million paired-end 100 base 
pair (bp) reads, with at least 88% mapped to the mouse genome (Supplementary Table 1). Most 
the transcriptome changes were in mRNA abundance, as we identified 4,882 differentially 
expressed genes between E18 and adult (>3.0 fold, Fig. 2.1 a). Comparative analysis of mRNA 
isoforms identified 529 AS events across 487 unique genes whose percent spliced in (PSI) values 
changed >20% (ΔPSI >20%), whereas 214 genes exhibited a >20% change in alternative 
polyadenylation (APA). A pie chart distribution of different types of AS is shown in the Fig. 2.2 
a. We tested 179 developmentally regulated AS events from RNA-Seq using reverse 
transcription PCR (RT–PCR) and validated 151 (~84%) of them (Fig. 2.2 b–d). Most AS events 
(58%) were multiples of three nucleotides, indicating variably spliced regions in the liver tend to 
preserve the reading frame. Remarkably, the overlap between mRNA abundance, AS and APA 
was marginal as only 141 genes (29% of AS events) changed at both steady-state mRNA levels 
and splicing, 55 genes (26% of 30 untranslated region (UTR) changes) changed at both mRNA 
levels and 3’UTR length, and eight genes changed in AS and in 3’UTR length (Fig. 2.1 a). Of the 
5,583 total events, only two changed significantly in mRNA levels, AS and 3’UTR length. 





length revealed enrichment in unique functional categories. For instance, the up or 
downregulated genes showed strong enrichment for ‘metabolic’ or ‘cell cycle’ related gene 
ontology functions whereas the alternatively spliced genes with increased, or decreased PSI 
values showed enrichment for ‘actin processes’ or ‘chromatin modification,' respectively (Fig. 
2.1 e, f). The class of genes with changes in APA showed over-representation for ‘protein 
transport and localization’ functions amongst enrichment for lysosomal and mitochondrial 
processes (Fig. 2.1 f). RNA-Seq analysis also showed that nearly three times as many genes 
decreased in abundance than increased during development (Fig. 2.1 b). While some genes 
changed significantly at either an early, middle or late stage, most genes fell into a distinct 
category of either continual increase or decrease from E18 to adult. AS transitions also showed 
similar temporal clusters. We found that nearly twice as many variably spliced regions showed 
increased inclusion than decreased over the postnatal period (Fig. 2.1 c). The strongest 
directional pattern of change, however, was in the 3’UTR length through APA. Of the 214 
affected genes, 145 (68%) showed preferential usage of distal poly (A) sites, thereby generating 
isoforms with longer 3’UTRs (Fig. 2.1 d). 
Conservation of AS transitions in murine and human livers.  
To determine if the developmental AS transitions identified in mouse liver were conserved in 
humans, we directly assessed splicing of 126 homologous regions in fetal and adult human liver 
samples. The bulk (55, 44%) of the AS events tested were found to be similarly regulated in both 
species (Fig. 2.3 a, b). Another 33 (26%) events were regulated in mouse but did not show a 
developmental change in humans, while 38 (30%) events that were alternatively spliced and 
regulated in mouse were either constitutively included or skipped in humans. The regulated 





were constitutive in humans (Fig. 2.4 a). As was witnessed in the mouse liver, the majority 
(78%) of AS changes in humans showed increased inclusion across time (Fig. 2.4 b). 
Collectively, these results not only demonstrate a strong correlative directionality in 
developmental regulation of AS events but also prelude a functional significance for regulated 
splicing transitions in hepatic maturation. 
Postnatal shift in AS is temporally coordinated. 
Analysis of RNA-Seq data, as started previously, showed that most genes showed a temporally 
regulated pattern of AS, with most genes either showing a continual increase or decrease in 
inclusion from E18 to Adult. Thus, to further understand the temporal dynamics of alternative 
splicing regulation during liver maturation, we performed splicing analysis of the 
developmentally regulated AS events at eight developmental timepoints that capture the entire 
spectrum of post-natal liver maturation. Livers were isolated from mice at the following 
timepoints: E16, E18, P0, P2, P7, P14, P28 and P90 (Fig.2.5 a). These timepoints represent 
distinct developmental changes that occur in the mouse. The embryonic timepoints represent the 
early immature state of the liver, P0 and P2 represent the decline of hematopoiesis and 
maturation of hepatocytes and cholangiocytes, the mice open their eyes around P7-P14 and start 
exploring and eating solid food in small amounts, P28 is when they are weaned and begin 
adolescence and P90 is when they are fully adult. Thus, analysis of splicing at these timepoints 
should shed light on the genes that are important for specific developmental stages and could 
point to the post-transcriptional regulation of genes in distinct pathways at these specific 
timepoints. Upon splicing analysis, we observed that subsets of splicing transitions follow 
distinct patterns of splicing change: Early (E16-P2), Late (P14-P90) and Biphasic i.e. they show 





temporally coordinated. It will be intriguing to study in further detail exactly how these genes 
influence the post-natal maturation of liver. Another interesting avenue of research is to 
determine which splicing factors influence the splicing of these subsets of genes 
Postnatal shift in AS is cell-type-specific and temporally coordinated.  
The liver is comprised of many different cells, but hepatocytes are the major parenchymal cell 
type and account for >75% of the adult liver volume(Si-Tayeb et al., 2010). Hepatocytes are 
epithelial in nature and form branching plates of cells between capillary sinusoids that connect 
the portal tracts to the central vein. The non-parenchymal cells (NPC) include cholangiocytes, 
hepatic stellate cells, sinusoidal endothelial cells and Kupffer cells. Notably, the fetal liver 
functions as a hematopoietic organ in mammals; however, by the end of gestation the 
hematopoietic progenitors exit the liver and migrate to the bone marrow(Si-Tayeb et al., 2010). 
Therefore, we asked whether the transcriptome changes identified were exclusive to the maturing 
parenchyma of the liver or were arising due to varying cell populations. To distinguish between 
the two scenarios, we isolated hepatocytes and NPC fractions from livers of P0 and adult Friend 
Virus B NIH Jackson (FVB/NJ) mice by enzymatic digestion and differential centrifugation. 
Total RNAs were extracted from the two liver cell fractions within 1 hr of animal sacrifice to 
minimize the effects of post-mortem changes and cell manipulation. Relative purity of the 
fractions was determined by RT–PCR analysis of cell-type-specific markers (Fig. 2.6 a). 
Comparisons of 132 AS events from purified hepatocytes, NPC and whole liver across two 
developmental stages revealed that the vast majority (~88%) of changes are detected in 
hepatocytes (Fig. 2.6 b, c). We extended our AS analysis to further determine the cell-type-
specificity. We found that while a substantial number of events (45, 34%) undergo similar 





undergo transitions that are cell type specific (Fig. 2.6 b, c). We further classified the AS events 
on the basis of whether the postnatal splicing change occurred in hepatocyte only, NPC only or 
opposite in NPC and hepatocyte fractions. Individual examples representing each of these 
categories are shown in Fig. 2.6 b. Although more than half of the cell-type-specific transitions 
(53%) were exclusive to hepatocytes, a significant number of events changed specifically in NPC 
(18%) or reciprocally in NPC and hepatocyte fractions (29%). This implies that postnatal 
transitions in the liver are primarily represented by regulation within hepatocytes and are not a 
consequence of a change in cell populations. While analyzing the directionality of the opposite in 
NPC and hepatocyte AS transitions, we noticed that 21 of 25 events displayed a crossover 
pattern (Fig. 2.6 d). That is, if the hepatocyte fraction showed a decrease in PSI of a variable 
region between P0 and adult, the NPC fraction showed an increase and vice versa. In contrast, 2 
of 25 events exhibited a convergent pattern. That is, while the PSI value of the variable regions 
at P0 stage was different between the hepatocyte and NPC fractions; their adult PSI values 
became indistinguishable (Fig. 2.6 d). Two of 25 events showed a strong divergent pattern. That 
is, the PSI value of the variable region at P0 stage was comparable in hepatocyte and NPC 
fractions, but their adult PSI value diverged in reciprocal directions (Fig. 2.6 d). Furthermore, we 
determined the temporal dynamics of cell-type-specific splicing differences (Fig. 2.6 e). We 
found that most AS transitions, especially the hepatocyte-specific events, happen early (maximal 
change occurs between E18 and P14) and that few events follow the middle (maximal change 
between P14 and P28) and late patterns (maximal change between P28 and adult) of splicing 
change. Together, these results highlight the remarkable complexity of the transcriptome that 






Expression of RBPs is temporally coordinated during postnatal liver maturation 
Our next goal was to identify the regulatory factor(s) that drive postnatal AS transitions in the 
liver. Whole liver RNA-Seq analyses revealed strong enrichment of ribonucleoprotein complex 
and RNA processing functions in the downregulated gene set (Fig. 2.1 e). Genes were cross-
referenced to the RNA-Seq data to identify DNA- and RNA-binding proteins that change >3-fold 
in expression during postnatal liver maturation. Direct comparison revealed that an 
overwhelming majority of RNA-binding proteins (96%) decreased postnatally (Fig. 2.7 a). In 
contrast, sequence-specific DNA binding proteins showed a similar overall pattern as ‘All genes.' 
qRT–PCR analysis of select RNA-binding proteins known to directly regulate splicing18 
demonstrated a high degree of overlap in their developmental expression pattern between mouse 
and human (Fig. 2.7 b). Consistent with the RNAseq data, qRT–PCR results confirmed a strong 
decrease in hepatic mRNA levels for most auxiliary splicing factors tested during development 
(Fig. 2.7 b). To check whether the protein expression levels reflect the same drop in expression 
as mRNA transcripts during liver development, we performed protein expression analysis at 
various developmental timepoints:  E16, E18, P0, P2, P7, P14, P28, and P90. We observed that 
most of the proteins tested decreased in expression during liver development, with the 
remarkable exception of ESRP2.The expression of RBPs follows distinct patterns, just like the 
AS transitions: early (E16-P2), Late (P14-P90) or Biphasic i.e. they showed a change in two 
stages (E16-P7 and P7-P90). It will thus be interesting to determine which AS transitions are 
governed by these splicing factors and exactly how does the decline of the expression of these 







Collectively, our results reflect that postnatal liver maturation is highly organized and is 
accomplished through at least three separate modes of transcriptome-remodeling events, namely 
mRNA abundance, AS and APA. We find different regulatory events target genes that function 
in more distinct than overlapping pathways. This signifies the discrete requirement of 
transcriptional and post-transcriptional regulatory modules in facilitating hepatic growth and 
development. Previous studies proposed that programmed changes in 3’UTR length by APA 
may affect mRNA stability of transcripts by changing the landscape of RNA-binding proteins 
and microRNAs available in a cell(Elkon et al., 2013). We demonstrate that mRNAs with altered 
3’UTR isoform ratios are largely unaffected at steady-state levels and therefore argue against a 
major role for APA in determining mRNA abundance during liver maturation. These results are 
consistent with a recent study that found genes changing in mRNA expression during biological 
transitions tend to have single 3’UTRs(Lianoglou et al., 2013). In contrast, the multi-UTR genes 
during such transitions predominantly change their 3’UTR ratios to achieve tissue 
specificity(Lianoglou et al., 2013). We also identified a conserved set of splice isoform 
transitions that switch from neonatal-to-adult pattern within the first two weeks after birth. While 
most of these AS transitions reflect changes in maturing hepatocytes, we discovered many are 
strictly NPC-specific. Of particular interest are the developmental transitions that when sampled 
in whole livers show no change in isoforms; however, when interrogated in purified hepatocytes 
versus NPC exhibit dramatic changes in isoforms but in opposite directions, which at the whole 
tissue level are diluted out. Intriguingly, the majority of the hepatocyte-specific splicing switches 
happen during the period when the liver encounters extensive physiological changes. For 





differentiation of hepatocytes and pronounced increase in binucleation and tetraploidy(Guidotti 
et al., 2003). The mice undergo significant dietary changes at this time as they transition from 
milk to chow(Girard et al., 1992; Jungermann and Katz, 1989a). Considering this, it is tempting 
to speculate that nutritional and hormonal variations between birth and weaning may serve as 
natural signals to initiate the postnatal splicing shift by modulating expression/activity of 









Figure 2.1. Remodeling of the liver transcriptome during postnatal development 
(a) Venn diagram showing the overlap of genes that change in mRNA abundance (>3-fold; p-value<0.01, 
Fisher’s Exact Test), alternative splicing (PSI>20%), and/or 3’UTR length ratio (>20%). (b) Heat map 
representation of 4882 genes that change significantly in expression from E18, P14, P28, and adult mouse 
liver developmental time points. Genes with early, middle and late changes showed a significant 
difference in expression only at one time point. (c) Heat map representation of 529 splicing changes 
across development. (d) Scatterplot of core and extended 3’UTR changes in adult and E18 mouse livers 
(>20% change). Gene Ontology analysis of significantly enriched pathways for genes (e) increasing and 
decreasing in mRNA abundance, (f) increasing or decreasing in PSI, and/or changing their 3’UTR length. 







Figure 2.2. Validation of alternative mRNA splicing during mouse liver development  
(a) Pie chart of the different types of alternative splicing (AS) events analyzed in this study. (b) Left panel 
shows RNA-Seq data displayed on the UCSC genome browser for each event. Right panel shows 
representative gel images of RT-PCR validation of the same AS events. The bands corresponding to (+) 
indicate exon inclusion and (-) indicates exon exclusion. E18 corresponds to embryonic day 18 and P28 
corresponds to postnatal day 28 liver samples. (c) Scatter plot showing comparison of RT-PCR and RNA-
Seq based ΔPSI (Difference in Percent Spliced In) values for 179 events. (d) Frequency Distribution table 









Figure 2.3. Conservation of developmentally regulated AS in mouse and human livers 
(a) Examples of mouse and human AS during liver development. The band corresponding to (+) indicates 
exon inclusion and (-) indicates exon skipping. Gene names are indicated on the left, and the differences 
in percent spliced in (ΔPSI) values are shown below each image. (b) Pie chart distribution showing 
splicing conservation in mouse and human liver development. 126 splicing events were tested side-by-








Figure 2.4. Conservation of splicing in mouse and humans during liver development  
(a) The table represents average sequence similarity for each of the three splicing categories and the 
number of exons that maintain the original frame of translation in mouse and human AS during liver 









Fig.2.5: Temporal analysis of splicing transitions in liver development.  
(a). A schematic depicting the eight timepoints used for the temporal analysis of splicing regulation 
during mouse liver development. E16 corresponds to the embryonic day 16, P0 corresponds to the post-
natal day 0 and so on. Mouse liver tissue at postnatal day 90 was used as the adult timepoint. (b) Line 
graphs showing various patterns in alternative splicing changes of the variable regions during mouse liver 
development. The x-axis represents the days in liver development; Y-axis represents the percent of total 
splicing change observed for each event. Gene names and the corresponding variable regions showing 
specific splicing patterns are indicated in each graph. The full set of splicing transitions were grouped and 









Figure 2.6. Cell-type-specificity of AS program during postnatal liver maturation 
(a) RT-PCR assays of cell-type-specific markers Afp (neonatal stage), Tdo (adult Hep), Ck19 
(cholangiocytes), Gfap (stellate cells), F4/80 (Kupffer cells), vWF (endothelial cells), and Gapdh (all 
cells) on RNA isolated from postnatal day 0 (P0) and adult (Ad) whole liver, hepatocytes (Hep), and non-
parenchymal cells (NPC). (b) Representative gel images for the developmentally regulated splicing 
events in whole liver, Hep, and NPC fractions. (c) Pie chart summarizing the breakdown of “similar” 
versus “cell-type-specific” splicing transitions. Bar graph showing the number of events regulated only in 
Hep, NPC, or in opposite direction. Individual splicing events were repeated on at least three independent 
pools of samples. (d) Classification and directionality of oppositely regulated splicing transitions during 
hepatocyte and NPC maturation. (e) Temporal dynamics of splicing transitions in hepatocytes and NPCs. 
Bar graph shows the proportion of cell-type-specific transitions that follow the early, middle, or late 








Figure 2.7. Hepatocyte-specific postnatal upregulation of Esrp2 mRNA and protein levels 
(a) Doughnut chart distribution showing number of genes increasing or decreasing in mRNA abundance 
(>3-fold) during mouse liver development (E18-Adult). The lists of nucleic acid binding proteins were 
obtained from the AmiGO 2 database. Direct comparison of “All genes” (4882) to sequence specific 
“DNA binding” (83) and “RNA binding” (313) proteins show a larger proportion of RNA binding 
proteins is downregulated. (b) Comparative analyses of transcript levels (qRT-PCR) of select auxiliary 
splicing factors during mouse (x-axis) and human (y-axis) liver development. Each data point represents 








Fig 2.8: Levels of RNA Binding Proteins undergo dramatic changes during mouse liver 
development. 
(a) Steady state levels of various RNA Binding Proteins (RBPs) were analyzed during mouse liver 
development by western blotting. Liver tissue from wild-type mice was collected at the various 
developmental timepoints as mentioned in the figure. Various RBP’s exhibit either early, late or biphasic 
decrease in protein levels during liver development. GAPDH was used as loading control and albumin 
(ALB)and C/EBPα were used as markers for liver development. (b) Line graphs depicting the relative 





CHAPTER THREE: ESRP2 IS A KEY REGULATOR OF POSTNATAL SPLICING 
PROGRAM IN MATURING HEPATOCYTES2 
 
ABSTRACT: 
Here we take a systematic approach to identify a highly conserved and temporally coordinated 
cell-type-specific splicing program, which is activated in part by epithelial splicing regulatory 
protein 2 (ESRP2) during postnatal period of liver development. Consistent with the failure of 
many neonatal- to-adult splicing transitions, Esrp2 null mice exhibit persistent expression of fetal 
markers and diminished mature hepatocyte characteristics. Conversely, ectopic expression of 
ESRP2 in immature mouse and human hepatocytes results in a reciprocal switch in splicing of 
genes involved in cell proliferation, adhesion, and differentiation. Phenotypic characterization of 
Esrp2 null livers reveals defects in hepatocyte proliferation, hepatic zonation abnormalities, and 
reduction in albumin production. Thus, our results define a conserved ESRP2 splicing regulatory 
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RNA binding proteins (RBPs) play pivotal roles in regulating splicing transitions by binding in 
cis near the variably used splice sites and modulating their accessibility to the 
spliceosome(Black, 2003).  Recent developments in deep sequencing techniques have enabled us 
to take a genome-wide look at the RBP targets as well as their protein partners. RBPs are 
involved in various aspects of mRNA regulation like maturation, stability, transport, and 
degradation. RBPs regulate the process of AS by positively or negatively influencing the 
inclusion or exclusion of exons. There are various classes of splicing factors which are expressed 
either ubiquitously or in a cell-type specific manner. The best known and well-studied examples 
are serine/arginine (SR) proteins and heterogenous nuclear ribonucleoproteins (hnRNPs)(Fu and 
Ares  Jr., 2014). However, RBPs also work in cell-type and tissue specific manner to coordinate 
the development and function of these tissues(Gerstberger et al., 2014; Kalsotra et al., 2008; Ule 
et al., 2005). These cell-type specific splicing regulators most often co-ordinate the splicing of 
genes linked to common biological processes, creating a splicing regulatory network. In this 
project, we have studied the role of an RBP named ESRP2(Epithelial Splicing Regulatory 
Protein 2), which is found to be specifically upregulated in maturing hepatocytes. 
Proteins in the ESRP family, ESRP1 (previously known as RBM35A) and ESRP2 (previously 
known as RBM35B), regulate a global epithelial splicing network(Warzecha et al.). Early cell 
culture studies identified ESRP1 and ESRP2 as epithelial cell-type specific regulators of FGFR2 
splicing and showed that ESRP protein levels drop during Epithelial-to-Mesenchymal Transition 
(EMT) causing a splicing switch in a number of ESRP-specific mRNA targets(Warzecha et al., 
2009). Further studies in both cell lines, as well as ESRP-specific mouse lines, established that 
ESRP proteins are components of an epithelial gene signature regulating a post-transcriptional 





Warzecha et al., 2010). ESRP proteins regulate the splicing of various genes associated with 
EMT-related functions like cell-cell adhesion, cell motility and cell-matrix adhesion(Warzecha et 
al., 2010). Studies in mice where the ESRP proteins were ablated demonstrated that ESRP 
proteins play an essential role in maintaining an epithelial-cell-type specific splicing program 
critical for proper development of many organs(Bebee et al., 2015). Global expression analysis 
of ESRP proteins showed that ESRP1 is largely expressed in tissues like epidermis, small 
intestine, large intestine, salivary gland, etc. Strikingly, we observed that in the liver, ESRP2 was 
predominantly expressed but not ESRP1. Therefore, I decided to study the role of ESRP in 
regulating splicing transitions during post-natal liver development. 
MATERIALS AND METHODS: 
Generation of Esrp2 KO mice.  
The Esrp2 KO allele was generated as part of the Knockout Mouse Project (KOMP) and 
purchased from Velocigene (C57BL/6NEsrp2tml(KOMP)vlcg). The Esrp2 gene locus was 
replaced by a LacZ and a floxed neomycin selection cassette. ES clone AG3 was injected into 
Balb/c blastocysts by the University of Pennsylvania Transgenic and Chimeric Mouse Facility, 
and resulting chimeras were crossed to C57BL/6J females for germline transmission. Genotypes 
were verified by tail biopsy PCR (Primers: E2 Common F: 5’-CGCGGGCGGGTCTCTGC-3’, 
E2 wild type R: 5’-CTCCCCTCCCCCTCGAAGTAGTGT-3’, and E2 KO R: 5’-
CAAATCTCCACTCCCCGTTCAAAG-3’) (wild type:638 bp, KO: 337 bp). Heterozygous 
Esrp2 +/_ mice were crossed to generate Esrp2_/_ KO mice. Whole liver tissues were isolated 
from 4-month old adult Esrp2 KO and wildtype (WT) mice for protein and RNA isolation as 






Motif analysis was carried out for four intronic regions flanking the exon of interest. Up to 250 
bases away from the corresponding exon–intron boundary were included. For introns, shorter 
than 500 bases, only half of the intronic regions were used. Similar methods as previously 
described(Kalsotra et al., 2008) were used for motif analysis and briefly described. For motif 
conservation, we analyzed sequence conservation of pentamers in the mouse intronic regions to 
identify potential splicing regulatory elements. The mouse introns were aligned to seven other 
mammalian genomes that have at least five sequence coverage in the UCSC 28-way 
multigenome alignment(Miller et al., 2007). For each pentamer in each region, a conservation 
rate (CR) was calculated as the fraction of aligned and conserved occurrences among total 
occurrences. The significance of CR of each pentamer is evaluated by comparing ten other 
pentamers with similar expected CR calculated using the first-order Markov model. This 
procedure essentially controls for possible sequence bias in the dataset. P value was calculated 
by using the binomial distribution. For motif enrichment, in order to account for background 
sequence biases, the introns corresponding to each region were binned according to their GC 
frequency into ten groups. Expected pentamer frequency was calculated for each pentamer by 
using the first-order Markov model in introns of each GC group respectively. Pentamer 
enrichment was then evaluated by comparing the occurrence frequency of each pentamer to the 
overall expected frequency calculated by summing up the expected counts of all GC groups. P 
value was calculated by using the binomial distribution. 
Gene Ontology (GO) and Pathway analysis 
For the ESRP2 Targets, the top individual GO terms (p-value < .01) were used. The ClueGo 





and GO enrichment network for ESRP2 targets. GO databases for Biological Processes, 
Molecular Functions, and KEGG were included in the analysis (Enrichment score= p-value 
<0.01). 
Protein isolation and Western blot analysis 
Proteins were isolated by homogenizing frozen liver tissue or purified cell fractions as previously 
described. HRP-conjugated rabbit monoclonal anti-ESRP1/2 (78 kDa; Rockland, 23A7.C9), 
mouse polyclonal anti-E-cadherin (135 kDa; BD Biosciences, 610181), goat polyclonal anti-
vimentin (51 kDa; Abcam, Ab11256), chicken polyclonal anti-albumin (66 kDa; Abcam, 
Ab106582), mouse monoclonal anti-N-cadherin (140 kDa; Life Technologies, 33-3900), goat 
polyclonal anti-pRB- Ser 780 (110 kDa; Santa Cruz, SC12901), rabbit polyclonal anti-Cyclin D1 
(36 kDa; Cell Signaling, 2922S), mouse monoclonal anti-TBP (38 kDa; Pierce, 51841), MBNL2 
(40 kDa; gift from T. Cooper), goat polyclonal anti-GAPDH (36 kDa; Santa Cruz, 20357) and 
goat polyclonal anti-β-actin (40 kDa; Santa Cruz, SC1616) were used. HRP-conjugated goat 
anti-mouse IgG light chain-specific (BioRad, 1706516), goat anti-rabbit IgG (Thermo, 31460), 
rabbit anti-goat IgG (Santa Cruz, sc-2922) and rabbit anti-chicken IgY (Pierce, 31401) secondary 
antibodies were used at 1:2000 to 1:5000 dilutions. 
Estimation of serum albumin 
Total proteins in serum of wildtype (n=6) and Esrp2 KOs (n=11) were determined by BCA 
protein assay kit (Thermo Scientific). 10 mL of diluted (1:50 in 1X PBS) serum samples were 
used to perform a western blot for albumin. The intensities of the bands obtained were quantified 
by ImageLab software (BioRad). Serum albumin per mg of protein was calculated by using the 





Estimation of albumin in Esrp2 KO and WT livers 
Total proteins were isolated from livers of wildtype (n=2), and Esrp2 KOs (n=4) mice and 
concentration was determined by BCA protein assay kit (Thermo Scientific). 50 μgs of the above 
proteins were used to perform a western blot for albumin. The intensities of the bands obtained 
were quantified by ImageLab software (BioRad). Albumin per mg of protein was calculated by 
using the following formula [intensity of albumin band X 1000]/ [total amount of protein loaded 
(i.e. 50 μg)]. The results for these were represented as box and whisker plots. 
Gene expression and splice isoform analysis 
Total RNAs were isolated from mouse livers or purified cell fractions using TRIzol reagent as 
previously described. Esrp1 and Esrp2 qRT–PCR assays were performed with predesigned 
TaqMan primers and probes according to the manufacturer’s instructions (Applied Biosystems). 
Histology and immunohistochemistry.  
Liver tissues from wildtype (n=3) and Esrp2 KO mice (n=3) were harvested and fixed overnight 
in 10% neutral buffered formalin, and then embedded in paraffin and sectioned (5 μm thickness). 
Hematoxylin and eosin (H&E) and trichrome staining were performed using standard 
histological methods. For immunohistochemistry, unstained slides were deparaffinized in 
xylenes (two treatments, 5 minutes each), rehydrated sequentially in ethanol (two minutes in 
100%, two minutes in 95%, two minutes in 80%,), and washed for three minutes in water. 
Antigen retrieval was performed by boiling the sections in Sodium Citrate buffer (10 mM 
Sodium Citrate, 0.05% Tween 20, pH 6.0) for 20 minutes at 100°C and cooled for 20 minutes. 
Endogenous peroxidase activity was quenched with a solution of 3% hydrogen peroxide solution 





Serum Albumin (BSA), 0.1% Triton X-100, 0.05%Tween 20 in 1X PBS) for 30 minutes and 
incubated with primary antibodies against E-CADHERIN (1:500, BD Biosciences 610181), Ki-
67 (1:500, BD Biosciences 550609), phospho-HIST3H3 Ser10 (1:100, Millipore 06-570), 
glutamine synthetase (1:1000, BD Biosciences 610518), PCK1 H-300 (1:50, Santa Cruz 
SC32879) or CYP2E1 (1:100, Millipore AB1252) at 4°C for 12 hours. After several washes, 
sections incubated with HRP-conjugated goat anti-mouse IgG light chain-specific antibody for 2 
hours. For visualization of the signal, DAB kit (Vector Labs) was used according to the 
manufacturer’s instructions. All intermediate washing steps were done using 0.1 M PBS, 0.5% 
Tween 20, pH 7.2, and all antibodies were diluted in 1X PBST with 1% BSA. Slides were sealed 
with a coverslip after lightly counterstaining with hematoxylin and photographed with an EVOS 
XL microscope. 
Quantification of cell area, ploidy, apoptotic, and proliferating cells 
Cell area of wildtype and Esrp2 KO liver sections was analyzed by wheat germ agglutinin 
(WGA) staining. Sections were dewaxed and washed with 1X PBS and incubated with 10 μg 
WGA-Alexa Fluor 488 for one hour at room temperature followed by additional washes with 1X 
PBS. Slides were mounted with DAPI containing hardset Vectashield mounting media (Vector 
Labs) and sealed with coverslips. The average cell area was quantified by choosing five random 
fields from each section and determining cell area for each cell in the field using ImageJ software 
(http://imagej.nih.gov/ij/) for wildtype (n=3) and Esrp2 KO sections (n=3). TUNEL assay was 
performed using Fluorescein-In situ cell death detection kit (Roche) to evaluate apoptosis. The 
same software and method of quantitation was used to enumerate total number of cells, mono 






Liver function tests 
Blood from wildtype (n=6) and Esrp2 KO (n=11) mice was collected by retro-orbital puncture in 
Capiject® gel/clot activator tubes and centrifuged for 10 minutes at 7500 X g, 4°C, and stored at 
-80°C until further analysis. Serum chemistry analyses of alanine aminotransferase (ALT), 
aspartate aminotransferase (AST), cholesterol and triglycerides were performed using specific 
assay kits and following the manufacturer’s protocols (Thermo Scientific). Random and steady 
state glucose measurements were done by collecting blood from wildtype (n=8) and Esrp2 KO 
(n=8) mice and detection using OneTouch® Ultra® 2 Blood Glucose Monitoring System. For 
fasting glucose levels, the mice were fasted for eight hours before measurement of glucose 
levels. 
Adenovirus Production and Cell Culture 
HepG2 and AML12 cell lines were obtained from ATCC (Catalogue no. HB-8065 and CRL-
2254, respectively) and cultured according to specifications as stated by ATCC. When tested for 
mycoplasma contamination (Biotool, catalogue no. B39032) prior to use, these cell lines tested 
negative. cDNAs encoding FLAG-tagged mouse Esrp(Warzecha et al., 2009) were sub-cloned 
into the p-AdenoX-ZsGreen1 vector (Clonetech, 632267) using the In- Fusion kit (Clonetech, 
639646) as per the manufacturer’s instructions. High-titer adenoviruses were generated by 
transfecting Ad-293 cells (~ 70% confluent) in T-25 flasks with linearized recombinant 
adenoviral plasmid using Mirus TransIT-2020 kit and cells were harvested once cytopathic effect 
(CPE) was seen. Following this, two viral amplification steps were performed, and the viral 
particles were purified using CsCl gradient as mentioned in the Adeno-X™ Adenoviral System 3 
user manual. After purification of viral particles, the titer was determined by UV 





and AML12 cells, T- 25 flasks containing ~50% confluent HepG2 and AML12 cells were 
infected with 1.5 X 109 opu (optical particle units) of the ESRP2 or GFP adenovirus for 48 hours 
and cells were harvested to extract RNA and protein for further analysis. 
Statistical Analyses 
Results are expressed as mean ± SD unless otherwise specified. Statistics were performed using 
the GraphPad Prism 6 software. Statistical significance was determined using two-tailed 
Student’s t-test (P<0.05). Correlation between Esrp2 KO and overexpression samples was 
carried out using Pearson’s product-moment correlation. The conservation of ESRP2 AS targets 
between mouse and humans was carried out using two-sample test for equality of proportions 
with continuity correction. 
RESULTS: 
ESRP2 is upregulated in hepatocytes during liver maturation 
Esrp2 and Muscleblind-like 2 (Mbnl2) exhibited significant mRNA upregulation in mouse and 
human liver development (Fig. 2.7 b). ESRPs (ESRP1 and ESRP2) are epithelial-specific 
splicing regulators that display an overlapping expression pattern in epithelial cells. They drive 
mesenchymal-to-epithelial transition by coordinating splicing of genes involved in cell-cell 
adhesion, cytoskeleton rearrangement, and intracellular signaling(Dittmar et al., 2012; Warzecha 
et al., 2010). We found that in comparison to Esrp1, Esrp2 is the primary paralogue expressed in 
both mouse and human livers (Fig. 3.1 a; Fig. 3.2 a). This is different from most other epithelial 
tissues where ESRP1 is more abundant(Warzecha et al., 2009). Furthermore, the developmental 
time course revealed a reciprocal expression pattern: Esrp2 mRNA levels increased while Esrp1 





increase in ESRP2 during the first four weeks after birth (Fig. 3.1 c). ESRP2 protein levels in the 
adult mouse liver are approximately 16-fold higher in comparison to the E18 stage. Despite a 
modest increase in transcript levels (Fig. 2.7 b), MBNL2 protein levels declined by 
approximately 3-fold in the adult liver (Fig. 3.1 c). As with mRNA expression, ESRP1 protein is 
undetectable in the adult human and mouse livers (Fig. 3.2). To determine whether the increase 
in Esrp2 expression is cell-type-specific, we assayed its relative mRNA and protein levels in 
purified hepatocyte and NPC fractions isolated from pooled P0 and adult mouse livers. We found 
that Esrp2 transcript levels increased 4-fold in adult hepatocytes versus the P0 stage (Fig. 3.1 d). 
Western blot analysis demonstrated a corresponding increase in ESRP2 protein levels, 
specifically in adult hepatocytes (Fig. 3.1 e). These results illustrate that Esrp2 expression is 
specifically induced in the maturing hepatocytes and that the timing of induction coincides with 
the developmental period (E18-P14) when most postnatal AS transitions occur (Fig. 2.6 e, 3.1 b 
& c).   
ESRP2 controls postnatal hepatic AS transitions 
To investigate whether ESRP2 plays a determinative role in the neonatal-to- adult shift of AS in 
the liver, we generated Esrp2 knockout (KO) mice (Fig. 3.3 a). Complete loss of Esrp2 mRNA 
and protein expression in the livers of homozygous ESRP2 knockouts is shown in Fig. 3.3 b, 
respectively. We next determined the AS pattern of 143 developmentally regulated events in 
adult livers of Esrp2 KOs and wildtype littermate controls. Thirty-one events were strongly 
misspliced in Esrp2 KOs of which 68% exhibited increased skipping, and 32% increased 
inclusion. Representative examples demonstrating the complete dependence of select postnatal 
splicing transitions in Esrp2 KO livers are shown in Fig. 3.3 c. In fact, over 96% of ESRP2 





obligatory for these physiological switches (Fig. 3.3 d). When evaluated for cell-type specificity, 
87% of ESRP2 targets were primarily regulated in hepatocytes (Fig. 3.3 d). We found that these 
targets are significantly enriched for GO terms related to actin-cytoskeleton and Rho/Ras 
signaling pathways (Fig. 3.4 a). Protein-protein interaction analysis revealed a connected 
network among targets with functional enrichment for “epithelial cell differentiation” and 
“phosphate containing metabolic process” (Fig. 3.4 b). ESRP binding motif UUGGG was 
significantly enriched in the upstream introns whereas the UGGUG motif was both enriched and 
conserved in the downstream introns flanking the ESRP2 regulated exons (Fig. 3.3 e). 
Furthermore, we observed prominent enrichment of the core ESRP motif immediately upstream 
of the variable regions whose PSI values increased in Esrp2 KO livers, compared to those with 
unchanged PSI values (Fig. 3.3 f). These results agree with the previous observation that ESRP 
binding upstream of the regulated exon represses its inclusion(Dittmar et al., 2012). Next, we 
determined whether ESRP2 regulated AS events are conserved between mouse and human 
hepatocytes. For this, we used human HepG2 and mouse AML12 hepatic cell lines, which have 
very low basal ESRP2 mRNA and protein levels and express a neonatal AS program (Fig. 3.5 a-
c). Strikingly, forced expression of ESRP2 reciprocally shifted AS from neonatal-to-adult 
patterns in both AML12 (24 of 31, 77%) and HepG2 (16 of 21, 76%) cells (Fig. 3.5 d-f). A 
highly significant (P < 2.664e-10, two-sample test for equality of proportions) negative 
correlation (R = - 0.87, Pearson’s product-momentum correlation) between Esrp2 KO and 
overexpression results indicates that developmentally regulated splicing of a subset of pre-
mRNAs is extremely sensitive to ESRP2 levels (Fig. 3.5 f). Furthermore, ESRP2 regulated AS 
events exhibit significantly higher mouse-to-human conservation (67%, P < 0.05, two-sample 





to background (44%, Fig. 2.1 b). Overall, these results provide compelling evidence that ESRP2 
is a conserved regulatory factor that is both necessary and sufficient to stimulate a subset of 
postnatal splicing transitions in hepatocytes. 
ESRP2 ablation causes defects in hepatic maturation and function 
Consistent with the splicing defects, Esrp2 KOs showed persistent expression of fetal genes and 
loss of mature hepatocyte markers including the EMT markers CDH1 and CDH2 (Fig. 3.6 a & 
b). Particularly, we found that the transcript and protein levels of positive cell cycle regulators 
(Ccnb2, Ccne1, Cdk1, and Cdk6; CCND1) are elevated, and the levels of cell cycle inhibitors 
(Cdkn1b and E2f8; p-RB) are reduced in the Esrp2KO livers (Fig. 3.6 a & b). While the Esrp2 
KOs showed normal hepato-somatic index and lobular organization, these mice displayed a 
substantial increase in the number of diploid and tetraploid hepatocytes that were considerably 
smaller in size relative to their littermate controls (Fig. 3.6 c-f). We also observed significantly 
higher hepatocyte proliferation in Esrp2 KOs as evidenced by increased Ki-67 and phospho-
histone 3 (pHIST3H3) staining (Fig. 3.6 d & g; Fig. 3.7 a). Esrp2 KOs did not exhibit any major 
signs of liver injury or changes in apoptosis, ALT, AST, cholesterol, triglyceride, or random and 
fasting glucose levels (Fig. 3.7 b & c). As some proteins during postnatal period develop region-
specific expression along the porto- central axis(Jungermann and Katz, 1989b), we performed 
immunohistochemical localization analyses to examine the impact of Esrp2 ablation on liver 
zonation. We found a significant reduction in periportal CDH1 and a relative expansion in the 
zone of PCK1 expressing periportal hepatocytes in the KO livers (Fig. 3.6 d and Fig. 3.8). While 
the restricted perivenous distribution of GLUL was maintained, the zone of CYP2E1 distribution 
was increased within the hepatic lobule of the KO livers (Fig. 3.8). We also observed a 





KOs (Fig. 3.6 h & i), which are likely due to decreased Alb mRNA abundance in the KOs.  
Together, these data demonstrate that ESRP2 serves an important role in terminal differentiation, 
hepatic zonation, and functional competence of hepatocytes. 
DISCUSSION:   
Our results establish ESRP2 as a key hepatocyte factor, which controls up to 20% of splice 
isoform transitions occurring naturally during the postnatal period of liver development. ESRPs 
are epithelial specific regulatory factors that bind to GU-rich motifs on pre-mRNAs and 
modulate splicing of alternative exons in a position- dependent manner(Dittmar et al., 2012; 
Warzecha et al., 2009, 2010). While previous studies have focused on ESRP1, we demonstrate 
that ESRP2 is the sole paralogue expressed in human and mouse livers and that it controls a 
highly conserved splicing regulatory network to facilitate terminal differentiation and postnatal 
maturation of hepatocytes. The gain- and loss-of-function studies reveal that not only is ESRP2 
necessary and sufficient for these AS transitions, but that there are detrimental functional 
consequences to the liver in its absence. For instance, characterization of Esrp2 KO mice 
revealed defects in cell proliferation, hepatic zonation, and albumin production. Consistent with 
these phenotypes, we find that many of the ESRP2 target exons are encoded in genes that control 
cell growth and proliferation, cell-cell adhesion and cell differentiation (Fig. 3.9). Amongst these 
are major components of Hippo (Nf2, Csnk1d, Yap1) and Rho/Ras GTPase (Arhgef10l, Arhgef11, 
Plekhg3, Kras, Sgsm1) signaling pathways as well as gene products involved in PI3K/AKT 
(Pdgfa, Vegfa, Usp4, Kras) and MAPK/ERK (Slk, Camkk2, Scrib, Cask) signaling 
pathways(Anjum and Blenis, 2008; Boggiano and Fehon, 2012; Cook et al., 2014; 





individual ESRP2 target transcripts and how their splice isoform switching affects hepatocyte 

























Figure 3.1. Hepatocyte-specific postnatal upregulation of Esrp2 mRNA and protein levels 
(a) Relative Esrp1 and Esrp2 mRNA levels in mouse and human adult livers. FPKM values for human 
ESRP1 and ESRP2 were obtained from the Human Protein Atlas Database (www.proteinatlas.org). (b) 
qRT-PCR analysis of Esrp1 and Esrp2 mRNA expression during mouse postnatal liver maturation. Each 
data point was normalized to Gapdh and represents fold change (mean ± SD) relative to E18. *P < 0.05, 
Student’s t-test (n=3). (c) Western blot showing induced ESRP2 and reduced MBNL2 steady-state protein 
levels during mouse liver development. Fold changes calculated by quantification of relative band 
intensities normalized to GAPDH are shown in parentheses on the right. Relative quantity and cell-type-








Figure 3.2. Expression of ESRP1 and ESRP2 in various tissues  












Figure 3.3. Esrp2 ablation leads to failure of postnatal AS transitions in the liver 
(a) Schematic showing the full Esrp2 gene replaced by homologous recombination to generate a knockout 
mouse. Colored arrows indicate the positions of primers designed to determine the genotype of Wildtype 
and Esrp2 KO mice. (b) qRT-PCR analysis showing complete loss of Esrp2 mRNA in liver tissue from 
Esrp2 knockout (KO) mice. Data (mean ± SD, n=4) were normalized to Gapdh (left). Western blot 
analysis demonstrating a complete loss of ESRP2 in Esrp2 knockout livers. GAPDH was used as loading 
control (right). (c) Representative gel images for the developmentally regulated splicing events (E18 vs. 
adult; FVB/N strain) in the adult wildtype and Esrp2 KO livers (C57BL/6 strain). Four representative 
splicing events that exhibit failure of neonatal-to-adult switch, and one representative event that remains 
unchanged in Esrp2 KO livers. (d) Pie-bar-pie representation showing number of ESRP2 regulated 
splicing events that exhibit a developmental shift towards the neonatal pattern in Esrp2 KO livers, and 
their cell-type specificity during normal development. (e) Conservation (eight mammalian species 
including human) and enrichment of ESRP binding motifs in the flanking introns of the ESRP2 regulated 
splicing events. Heat maps representing P values for significance of indicated motifs in positions 12 to 
250 of the upstream intron (upIn1), positions -250 to -31 of the upstream intron (upIn), positions 12 to 
250 of the downstream intron (dnIn), and positions -250 to -31 of the downstream intron (dnIn2) are 
shown on the right. P-values were calculated using binomial distribution (f) Enriched ESRP2 motifs 
upstream and downstream (±150 bp) of ESRP2-sensitive alternative regions were identified. The light 
blue, orange, and grey lines indicate the distribution of the UGG core motif around the ESRP2 regulated 







Figure 3.4. Analysis of the ESRP2 regulated splicing network in the liver  
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Figure 3.5. ESRP2 regulates a conserved set of postnatal AS transitions in hepatocytes  
(a) qRT-PCR analysis of ESRP2 mRNA levels in fetal, adult human liver samples, and HepG2 cells (left 
panel); E18, adult mouse liver samples, and AML12 cells (right panel). mean ± SD. (b) Adenoviral 
overexpression of GFP and ESRP2 in AML12 and HepG2. (c) Western blot demonstrating increased 
expression of FLAG-tagged ESRP2 in AML12 and HepG2 cells infected with the adenovirus. Scale bars, 
400 µm (d) Splicing assays of ESRP2 target genes using human fetal, adult liver tissue samples, and 
HepG2 cells (left panel); E18, adult mouse liver tissue, and AML12 cells (right panel). (e) Four 
representative AS events that exhibit a neonatal-to-adult shift in splicing upon adenoviral ESRP2 
overexpression in AML12 and HepG2 cells. (f) Heat map of ΔPSI values (Adult-P0) of AS events in 
Hepatocytes/NPCs with an overlap between AS events that exhibit reciprocal regulation between Esrp2 
KO livers and ESRP2 overexpression in AML12 cells. (g) Venn diagram of conserved AS regulation 








Figure 3.6. Histological and functional defects in the livers of Esrp2 KO mice  
(a) Western blot analysis demonstrating a decrease in E-cadherin (CDH1) and Retinoblastoma (pRB) and 
an increase in N-cadherin (CDH2) and Cyclin D1 (CCND1) protein expression in Esrp2 KO livers. 
GAPDH and TBP were used as loading controls. (b) qRT-PCR analysis of cell cycle regulators as well as 
neonatal and adult hepatocyte markers in wildtype (WT) and Esrp2 KO livers (n=3). (c) Bar graph of 
hepato-somatic index of WT and Esrp2 KO mice. mean ± SD (d) Hematoxylin and Eosin (H&E) staining 
of WT and Esrp2 KO liver tissues. Yellow arrows indicate binucleated cells, Scale bars, 400 µm; WGA- 
and DAPI-stained liver tissue sections representing cell size and number in WT and Esrp2 KO mice, 
Scale bars, 100 µm; increased number of Ki-67 positive cells in Esrp2 KO livers (green arrows) Scale 
bars, 400 µm; E-cadherin (CDH1) immunostaining measuring periportal zonation of WT and Esrp2 KO 
livers. Scale bars, 200 µm Quantification of (e) hepatocyte cell area, mean ± SD; (f) cell number, mean ± 
SD; (g) ploidy, mean ± SD; (h) Bar graph showing a decrease in total serum protein levels in Esrp2 KO 
(n=11) as compared to WT mice (n=6). mean ± SD (i) Box-whisker plot demonstrating a decrease in 







Figure 3.7. Phenotypic characterization of Esrp2 KO mouse 
(a) Increased number of phospho-histone 3 (pHIST3H3) positive cells in Esrp2 KO livers (green arrows), 
Scale bars, 200 µm; quantification of Ki-67 and pHIST3H3 positive cells. mean ± SD (b) No significant 
difference in apoptosis between WT and Esrp2 KO animals as shown by TUNEL assay, Scale bars, 100 
µm. White arrows point to apoptotic nuclei. Bar graph indicates the quantification of an average number 
of apoptotic cells per field in WT and Esrp2 KO sections. mean ± SD (c) Blood serum levels of ALT, 
AST, cholesterol, triglycerides, random and fasting glucose levels of WT and Esrp2 KO mice. mean ± SD 








Figure 3.8. Characterization of liver zonation in Esrp2 KO mice 
No apparent fibrosis in WT or Esrp2 KO animals as evidenced by trichrome staining; reduced and 
diffused periportal marker phosphoenolpyruvate carboxykinase (PCK1) staining in Esrp2 KO compared 
to WT; no difference in perivenous staining of glutamine synthetase (GLUL); slightly diffused 









Figure 3.9. ESRP2 controls AS of cell proliferation and differentiation related genes  
Schematic diagram illustrating the network of proteins containing ESRP2 regulated alternative exons. 
ESRP2 targets in yellow bubbles are known to play roles in cell growth and proliferation by interacting 
with other cellular proteins (white bubbles). ESRP2 targets in grey bubbles play roles in other cellular 






CHAPTER FOUR: DETERMINATION OF THE ALTERNATIVE SPLICING 
PROGRAM DURING LIVER REGENERATION3 
 
ABSTRACT: 
To systematically study the AS transitions impacted during regeneration, I performed a high-
throughput RNA-sequencing screen on regenerating livers, using a toxin-based liver injury and 
regeneration mouse model available in our laboratory. I have previously identified AS transitions 
that are regulated during postnatal liver development. I used these two data sets to find the subset 
of AS events that are not only developmentally regulated but are also redeployed during 
regeneration. I also tested the expression of various RBPs during liver regeneration and found 
that expression for most of these RBPs goes up during regeneration opening up further avenues 
of study. 
INTRODUCTION 
Tissue regeneration is a vital mechanism in mature organisms to recover from injury. The 
mammalian liver has a central role in detoxification and therefore is exposed to a variety of 
toxins. Owing to this, the liver has a unique capacity to undergo robust regeneration in response 
to damage(Michalopoulos, 2007, 2011). However, impaired regeneration pathways are seen in 
many liver disorders, making liver failure one of the major causes of death on a global level.  
Thus, there is an urgent need to understand the regulatory networks governing liver regeneration. 
                                                          
3 Arif W*, Bangru S*, Bhate A, Seimetz J, Rashan EH, Yum K, Anakk S, Carstens RP, Kalsotra A. Activation of an early postnatal 
program is critical for liver regeneration. Manuscript under preparation 
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The molecular mechanisms that drive this terminally differentiated tissue into a proliferative and 
hypertrophic state remain elusive.  
During drug detoxification, a major function of the liver, hepatocytes are exposed to many toxins 
that can induce cell death and injury. The regenerative ability of liver helps with its rapid tissue 
repair without adversely affecting the ability of the liver to perform the homeostatic functions at 
its optimum.  Liver regeneration is primarily brought about by the proliferation of hepatocytes 
and other mature cell types followed by increased angiogenesis and restructuring. Earlier, studies 
have indicated that the stem cell population of the liver is responsible for the regenerative 
capacity of the liver, but current research indicates that it is the polyploid, existing hepatocytes 
that re-enter the cell cycle giving rise to new hepatocytes(Schaub et al., 2014; Usbdjoh et al., 
2011; Yanger et al., 2014).  As the hepatocytes, must re-renter the cell cycle in response to the 
regeneration cues, it is suggested that these hepatocytes de-differentiate to an immature stage. 
This implies that the transcriptome of these actively regenerating hepatocytes mimics the early 
post-natal pattern.  The regulation of this process by various signaling cascades involving growth 
factors, cytokines, etc. has been extensively studied(Kung et al., 2010; Kyrmizi et al., 2006). 
However, the regulatory role of transcriptome remodeling by alternative splicing during liver 
regeneration so far has not been studied.  
An actively regenerating liver requires a variety of proteins to not only support the increased 
hepatocyte proliferation but also maintain inherent liver function. Therefore, there must be 
mechanisms in place that allows for the selective and dynamic remodeling of the regenerating 
hepatocytes.  I have previously shown that ESRP2 turns on an adult splicing program in 





differentiation(Bhate et al., 2015). Therefore, I that ESRP2 expression levels are dynamically 
modulated during liver regeneration.  
In this chapter, I describe the details of the study regarding the role of AS in liver regeneration 
that I helped initiate. This analysis will help us take a closer look at the individual genes that 
undergo AS upon liver injury, leading to the identification of key pathways that are switched on 
during liver regeneration.  
MATERIALS AND METHODS: 
Materials: 
0.1% DDC Diet was purchased from Harlan. Normal chow also obtained from Harlan. 
Animal Models: 
We used FVB/N wild-type mice for this study following the NIH guidelines for use and care of 
laboratory animals. All experimental protocols were approved by IACUC (Institutional Animal 
Care and Use Committee at University of Illinois, Urbana-Champaign). This study uses age-
matched male and female mice for all experiments, as the study is not gender specific. 4-6 mice 
were used for each experimental group. The experimental groups were as follows: mice fed with 
control/normal chow and mice fed with 0.1 % DDC diet for 2,4, and eight weeks. Individual 
body weights were recorded on a weekly basis for all these mice during the experimental period. 
Whole liver tissues were isolated from these mice for protein, RNA isolation as well as 
histological staining and blood was collected for serological tests. Another experimental setup 
included FVB animals treated with 0.1% DDC diet for four weeks and then switched back to 
normal/control diet for 2 and four weeks. At the end of which whole livers and blood were 





identification numbers by ear tagging. Only ear tag numbers were used to identify the individual 
animals at the time of performing histological studies, serum biochemistry and liver function 
tests to keep the study double-blinded.  
Hepatocyte and NPC isolation: 
For the cell-type specific study, hepatocytes, and non-parenchymal cells were isolated from 
FVB/N mice on normal/control diet, on 0.1 % DDC diet for 4 weeks and mice which were fed 
0.1 % DDC diet and then were switched back to normal diet for 2 weeks for protein and RNA 
isolation according to a protocol already established in the lab. Isolated Hepatocytes and NPCs 
were used for RNA and Protein isolation. 
RNA-Seq: 
RNA was isolated from experiment specific mouse livers using RNeasy tissue mini-kit (Qiagen). 
Downstream RNA quality was assessed using an Agilent bioanalyzer and quantified using a 
Qubit Fluorometer by the Functional genomics core at the Roy J. Carver biotechnology center, 
UIUC. Hi-Seq libraries were prepared, and 100 bp paired end Illumina sequencing was 
performed on a HiSeq 4000 at the High throughput sequencing and genotyping unit, UIUC. 
RNAseq reads were processed for quality and read length filters using Trimmomatic(Bolger et 
al., 2014). RNAseq reads were further aligned to the mouse genome (mm10) using an existing 
mapping software, STAR(Dobin and Gingeras, 2015). Mapping percentage and sample details 
are provided in respective supplementary figures. Gene expression levels were determined as 
Transcript per million (TPM) using count and differential expression values obtained from 
DESeq2, and HTseq(Anders et al., 2015). Genes were considered as having significant 





|Log2 (Fold Change)| > 1). Differential splicing analysis was performed using rMATS, and 
significant events were identified using imposed cutoffs (FDR < 0.10, Junction read counts • 10, 
percent spliced In • 15%)(Shen et al., 2014). Gene ontology analysis was performed using 
DAVID and mapped using Enrichment maps plugin in Cytoscape. Mouse reference gene set 
served as background, and the biological function (BP) category was analyzed with three 
pathways (Biocarta, Kegg, and Panther). Functional clustering was performed and top clusters 
(p-value < 0.05) represented.) 
RNA isolation and Splice isoform analysis: 
RNA isolation from liver tissues of FVB mice fed with normal chow, 0.1% DDC Diet, and 
recovery mice was performed using the previously described protocol. Splice isoform analysis to 
detect regeneration specific events was also performed as previously stated. 
Liver function tests 
Blood from FVB/N wild-type mice from all experimental groups was collected by a retro-orbital 
puncture in Capiject® gel/clot activator tubes and centrifuged for 10 minutes at 7500 X g, 4°C, 
and stored at -80°C until further analysis. Serum chemistry analyses of alanine aminotransferase 
(ALT), aspartate aminotransferase (AST), total Bilirubin were performed using specific assay 
kits and following the manufacturer’s protocols (Thermo Scientific).  
Histology, immunohistochemistry and fluorescent staining.  
Liver tissues from FVB mice on control, 0.1% DDC Diet and recovery were harvested and fixed 
overnight in 10% neutral buffered formalin, and then embedded in paraffin and sectioned (5 μm 
thickness). Hematoxylin and eosin (H&E) and trichrome staining were performed using standard 





deparaffinized in xylenes (two treatments, 5 minutes each), rehydrated sequentially in ethanol 
(two minutes in 100%, two minutes in 95%, two minutes in 80%,), and washed for three minutes 
in water. Antigen retrieval was performed by boiling the sections in Sodium Citrate buffer (10 
mM Sodium Citrate, 0.05% Tween 20, pH 6.0) for 20 minutes at 100°C and cooled for 20 
minutes. Endogenous peroxidase activity was quenched with a solution of 3% hydrogen peroxide 
solution (Fisher Scientific). After washing, sections were blocked (2% normal goat serum, 1% 
Bovine Serum Albumin (BSA), 0.1% Triton X-100, 0.05%Tween 20 in 1X PBS) for 30 minutes 
and incubated with primary antibodies against Ki-67 (1:500, BD Biosciences 550609), phospho-
HIST3H3 Ser10 (1:100, Millipore 06-570), HNF4A-α (1:500, Abcam ab41898), KKRT19 
(1:500, Abcam ab15463) at 4°C for 12 hours. For immunohistochemistry, after several washes, 
sections incubated with HRP-conjugated goat anti-mouse IgG light chain-specific antibody for 2 
hours and DAB kit (Vector Labs) was used for visualization. All intermediate washing steps 
were done using 0.1 M PBS, 0.5% Tween 20, pH 7.2, and all antibodies were diluted in 1X 
PBST with 1% BSA. Slides were sealed with a coverslip after lightly counterstaining with 
hematoxylin and photographed with an EVOS XL microscope. For immunofluorescent staining, 
after several washes in the dark, slides were incubated with goat anti-Mouse IgG (H+L) Cross-
Adsorbed Secondary Antibody, DyLight® 488 and Goat anti-Rabbit IgG (H+L) Cross-Adsorbed 
Secondary Antibody, DyLight® 594. Nuclei were stained using To-Pro™-3 Iodide using 
manufacturer’s protocol (ThermoFisher Scientific, T3605) and imaged using LSM 710 confocal 
microscope. 
Protein isolation and Western blot analysis 
Proteins from livers of FVB mice on control, 0.1% DDC Diet and recovery were isolated using 





Rockland, 23A7.C9), mouse monoclonal anti-TBP (38 kDa; Pierce, 51841), mouse monoclonal 
anti-SRSF1 (27 kDa; ThermoFisher Scientific, 32-4600), rabbit polyclonal anti-hnRNP H (50 
kDa; Abcam, ab10374), mouse monoclonal anti-hnRNP A1 (41 kDa; Millipore, 04-1469), 
mouse monoclonal anti-hnRNAP L (64 kDa; Abcam, ab6106), rabbit polyclonal anti-hnRNP LL 
(61 kDa; Cell Signaling, 4783S) rabbit polyclonal anti-RBFOX2 (47 kDa; Bethyl, A300-864A), 
mouse monoclonal anti-CELF1 (52 kDa; Santa Cruz, SC20003), mouse monoclonal anti-PTBP1 
(57 kDa; ThermoFisher Scientific, 32-4800), chicken polyclonal anti-albumin (66 kDa; Abcam, 
Ab106582), goat polyclonal anti-VIMENTIN (51 kDa; Abcam, Ab11256), MBNL2 (40 kDa; 
gift from T. Cooper), goat polyclonal anti-GAPDH (36 kDa; Santa Cruz, 20357) and goat 
polyclonal anti-β-actin (40 kDa; Santa Cruz, SC1616) were used. HRP-conjugated goat anti-
mouse IgG light chain-specific (BioRad, 1706516), goat anti-rabbit IgG (Thermo, 31460), rabbit 
anti-goat IgG (Santa Cruz, sc-2922) and rabbit anti-chicken IgY (Pierce, 31401) secondary 
antibodies were used at 1:2000 to 1:5000 dilutions. 
Statistical analysis:  
Results are expressed as mean ± SD unless otherwise specified. Statistics were performed using 
the GraphPad Prism 6 software. Statistical significance was determined using two-tailed 
Student’s t-test (P<0.05). 
RESULTS: 
AS transitions during mouse liver regeneration were identified by RNA-Seq: 
I used DDC (3, 5-diethoxycarbonyl-1, 4-dihydrocollidine), a known hepatotoxin, to induce liver 
regeneration in mice. This established model of liver regeneration closely mimics the normal 





diet for 2,4,6,8 weeks and livers collected for gross histology, RNA and protein extraction (Fig. 
4.1 a). Histological analysis showed that the regeneration response had fully set in by four weeks 
of DDC treatment (Fig. 4.1 b-e). This showed that the toxin based liver regeneration model was 
working. Further analysis showed that the regenerating livers go back to their normal state within 
four weeks of recovery, i.e. after the DDC diet regiment, upon feeding normal chow for four 
weeks, the livers show recovery (Fig 4.2). To determine whether resident hepatic progenitor cells 
or existing hepatocytes under proliferation in response to injury to contribute towards liver 
regeneration, co-immunostaining was performed with HNF4Aα, hepatocyte marker, and 
pHIST3H3, marking proliferating cells (Fig 4.2 b). We observed that the majority of 
proliferating cells were hepatocytes (Fig. 4.2 b, d). As the proliferation response was fully set in 
by four weeks of DDC treatment, this timepoint was used for performing RNA-Seq on these 
regenerating livers to characterize the AS program during liver regeneration. The RNA-Seq data 
showed that in response to toxin injury, ~3000 genes changed in mRNA abundance, and 238 
events showed differences in AS in regenerating livers (Fig. 4.3 a). Strikingly, there was minimal 
overlap in the genes changing in mRNA abundance as AS. Gene Ontology analysis of 
upregulated genes show enrichment for cell cycle pathways, whereas downregulated genes show 
enrichment for metabolic functions (Fig.4.3 b). GO for AS events show enrichment for 
transcription regulation, RNA processing and embryonic development pathways (Fig. 4.3 c). 
These findings are in line with the biological process that is needed to support the proper 
functioning of the liver, as well as large-scale hepatocyte proliferation in response to 
regeneration cues. 






The long-held notion was that the regenerative capacity of the liver arises dues to the facultative 
stem cell population in the liver. But, various studies now point to the fact that new hepatocytes 
generated during liver regeneration are derived from the pre-existing polyploid hepatocytes. Our 
results also prove that majority of proliferating cells (PH3+) are hepatocytes, as evidenced by 
HNF4α co-localization (Fig. 4.2 b, d). Therefore, as the regenerating liver has actively 
proliferating hepatocytes, it could be thought to have similar characteristics of an immature liver. 
Therefore, upon comparing the dataset of developmentally regulated AS events with the list of 
genes that are differentially spliced in regeneration we find that there is a large subset of AS 
events common to both. Upon performing GO of these overlapping events that changed in 
mRNA abundance and AS, we found enrichment for similar categories but in the opposite 
direction, i.e. the pathways that were upregulated during development are downregulated in 
regeneration (Fig. 4.4 a, b). Splicing of these common events is in reciprocal direction for 
development and regeneration, indicating that these events start exhibiting neonatal-like splicing 
pattern during regeneration (Fig. 4.4 c, d). This suggests that regenerating livers redeploy in part, 
a regulatory program that is used during normal hepatic maturation.  
Expression of developmentally regulated RBPs is selectively modulated during liver 
regeneration: 
Our previous analysis shows that many RBPs are strongly down regulated during postnatal liver 
development (Fig 2.8). We also observe that regenerating livers mimic an immature phenotype, 
as evidenced by the redeployment of a subset of AS events which are developmentally regulated. 
Thus, to gain complete knowledge of the regulatory networks governing liver regeneration, we 
looked at the expression of RBPs in regenerating livers. Most RBPs whose protein levels were 





mRNA levels of these RBPs reflect overlapping changes in expression. As we know that pre-
existing hepatocytes reenter cell cycle to give rise to new hepatocytes during DDC induced liver 
regeneration, we tested the RBP expression levels in hepatocytes isolated from DDC treated 
livers (Fig. 4.5 b). These RBPs showed similar expression in Hep isolated from livers treated 
with DDC indicating that these factors may play a role in governing the AS landscape during 
regeneration (Fig. 4.5 a). Interestingly, ESRP2 mRNA and protein expression was 
downregulated in 4 week DDC livers and hepatocytes and restored in livers in 4-week recovery 
from DDC diet treatment (Fig. 4.6 a). A few of the ESRP2 specific AS events also showed a 
change in their splicing pattern during regeneration (Fig 4.6 b). Thus, further studies need to be 










Figure 4.1. Phenotypic characterization of DDC mediated liver regeneration model.  
(a) Schematic diagram explaining the experimental set-up. (b) Images of whole mouse livers on normal 
chow compared to mice on DDC diet for 4 weeks. (c) Box and Whisker plot of hepato-somatic index of 
control (normal chow) and DDC treated mice (2,4,8 weeks). Mean ± SD, p-value < 0.0001 (d) Serum 
enzyme levels in control (normal chow) and DDC treated mice (2,4,8 weeks) (e) Hematoxylin and Eosin 
(H&E) staining of control and DDC treated liver tissues (green arrows point to bile lakes, black arrows 
point to inflammation); increased cell proliferation in DDC treated livers demonstrated by Ki-67 
immunostaining (red arrows show Ki-67 positive cells); increased number of bile ducts demonstrated by 






Figure 4.2. Phenotypic evaluation of liver response to 0.1% DDC treatment. 
(a) Schematic for the study plan. (b) Histological and Immunofluorescence (IF) analysis of FVB mice 
post 4 week 0.1% DDC diet regimen and 4-week recovery. (c) Liver to body weight (Hepatosomatic 









Figure 4.3. Regenerating livers undergo coordinated expression and splicing changes in response to 
damage. 
(a) Transcriptome analysis using Cufflinks showed that 2,839 protein coding genes and 146 lincRNA 
genes were differentially expressed. (b) rMATS tested 35,421 splicing events. All possible events were 
plotted by ΔPSI with significant events displayed as blue. The table below shows significant events 
broken down by type. (c) Comparing significant expression changes with significant splicing events 
reveals three distinct groups of transcriptome changes: expression only, splicing only and both expression 
and splicing. (d-f) Gene Ontology analysis of significant upregulated genes (d), downregulated genes (e) 








Figure 4.4 Transcriptome changes in regenerating livers resemble developmental expression and 
splicing programs.  
Developmental transcriptome elements are red, and regeneration elements are blue. (a) Comparison of the 
top fourteen gene ontology categories of upregulated and downregulated genes during regeneration. Gene 
ontology of developmentally regulated genes show an inverse expression pattern, indicating regenerating 
livers undergo changes to become more embryonic like. (b) The top fourteen gene ontology categories for 
post-transcriptionally regulated genes during regeneration, along with the corresponding categories of 
developmental splicing changes. There is a large overlap of the regeneration and developmental splicing 
programs. (c) Heat map of mRNAs changing in splicing patterns show that regeneration and 
developmentally regulated gene sets are reciprocally regulated. (d) Representative gel images for the 







Figure 4.5. Expression of RNA Binding proteins during regeneration. 
(a) Western blots showing the expression of various splicing factors in whole livers and Hepatocytes 
isolated form mice on normal chow or 0.1%DDC diet for 4 weeks. (b) Histograms showing the fold 
change in protein and mRNA expression after DDC treatment of 4 weeks. Westerns blots are normalized 








Figure 4.6. ESRP2 specific splicing changes and recovery from regeneration. 
(a) Western blots showing the expression of ESRP2 in mice on normal chow, 0.1%DDC diet, recovering 
from DDC Diet for 4 weeks. (b) Representative Gel images of ESRP2 regulated splicing events during 






CHAPTER FIVE: FUTURE DIRECTIONS AND CONCLUSIONS 
 
Thus far, from work in this project, we have determined that postnatal liver maturation is an 
extremely structured process and needs the coordination of at least three separate modes of 
transcriptome remodeling events. We also find that ~20% of the transcriptome in a maturing 
liver is regulated by ESRP2. Further, preliminary studies of transcriptome remodeling during 
liver regeneration point to the fact that a subset of developmentally regulated genes is redeployed 
during liver regeneration and ESRP2 might play a role in this. Therefore, by continuing to study 
these findings in further detail, we will gain detailed insights of the changes in the post-
transcriptional landscape during liver regeneration. This will be the first study to explore the 
regulatory role of AS during liver regeneration. We will also gain insight into how regenerative 
AS programs govern the different cell-types of the liver during liver regeneration. Furthermore, 
by identifying the subsets of developmentally regulated splicing events that are redeployed 
during liver regeneration, we will be able to determine the shared gene which might be used as 
candidates for therapeutic applications. To take these studies further, we have several avenues to 
explore.  
The first direction to take is to determine whether liver regeneration is cell type specific. During 
histological analysis of DDC treated livers, we observed that these livers have a massive 
inflammation response. Thus, the RNA-Seq of 4 week DDC treated livers does not capture the 
transcriptomic changes of the proliferating hepatocytes, which are the primary functional cells of 
the liver. One surefire way to circumvent this is to perform RNA-Seq on hep from 4 week treated 
livers and analyze the transcriptome changes to identify hep-specific changes and compare with 





Furthermore, these transcriptomic changes should also be validated in a different model of 
regeneration, i.e. partial hepatectomy (PHX). PHX involves surgically removing 2/3rd of the liver 
and observing the regeneration response. It is quite possible that different regulatory mechanisms 
might be triggered in these two distinct liver regeneration models, as PHX requires an immediate 
proliferative response by the liver, but toxin-based model develops more slowly. The next logical 
direction to take is to characterize the role of ESRP2 during mammalian liver regeneration. We 
have shown that ESRP2 is required for proper maturation and functioning of hepatocytes. 
Therefore it will be interesting to investigate the role of ESRP2 in liver regeneration. Data also 
shows that Esrp2 mRNA and protein levels are downregulated in regenerating livers and restored 
in recovering livers. Therefore, the AS transitions regulated by ESRP2 should be investigated. 
To effectively study this, it is imperative to find the direct targets of ESRP2 in the liver. The lab 
now has generated liver specific ESRP2 KO and OE mice. This will provide invaluable tools to 
study both loss and gain-of-function effects of ESRP2 in the liver and comprehensively 
understand the role of ESRP2 in both liver maturation as well as regeneration. 
The liver is a dynamic organ which undergoes a great change in its composition and function 
during its development and maturation period. Many mechanisms are needed to coordinate this 
change, and this thesis has shown for the first time the role of post transcriptional mechanisms 
for the same. We have just scratched the surface, and further detailed studies must be performed 
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APPENDIX A: SUPPLEMENTARY MATERIALS 
 
 
Table A.1: RNA-Seq Analysis 




E18 Rep 1 101x2 180938383 145942251 80.66 
E18 Rep 2 101x2 178525892 135916997 76.13 
PN14 Rep 1 101x2 180883962 160106559 88.51 
PN14 Rep 2 101x2 182078832 160419344 88.1 
PN28 Rep 1 101x2 177819963 136171970 76.58 
PN28 Rep 2 101x2 185963653 152248825 81.87 
Adult Rep 1 101x2 161036868 115178526 71.52 
Adult Rep 2 101x2 187374633 127733909 68.17 
Chow 1 101x2 75775964 63036233 83.19 
Chow 2 101x2 87542785 73763935 84.26 
DDC 1 101x2 58696229 53444319 91.05 









Table A.2: Primer Sequences   
Gene name Primer Sequence (5'-3')  Amplicon  
 Forward Reverse Size 
Mouse Primers for qRT-PCR assays   
Celf1 CAGATTGAAGAGTGCCGGATA TAGCTGTCTGTGCCATGGTT 97 
Celf2 ACTTGGGGGAACCTAACAGG CTGAATGCCACTGAATGCAC 105 
Esrp2 TATAAAGCCACAGGGGAGGA TCTTCCCGTGATAGGAAACG 79 
Hnrnp A ATTTTGGTCGAGGAGGGAAC ATTATAGCCATCCCCACTGC 92 
Hnrnp H GCAGAGGAGCTGGTTTTGAG GAACCAAATCCATAGCCATCA 102 
Hnrnp L CTGCTTGTATGGCAATGTGG AGCATAGCCATCAGCCATTT 85 
Hnrnp LL CTGGCTCCGTTGTAATGGTT GTGCCAGGAATGGTCTTCAT 124 
Mbnl1 GGAGTTCCAGTGCCAGCAG CACGCTGGTACTCTCGACAC 88 
Mbnl2 GGCTCAACTGCAACTCAGAA AGCGGCAGTCTGTCTCTCC 100 




Srsf2 CCACCCCGTCGGTACG CGACCTGGACCGACTCC 99 
Cyp2b10 TGCTGTCGTTGAGCCAACC CCACTAAACATTGGGCTTCCT 161 
Albumin TGCTGAGACTTGCCAAGACA TCCATATTCTCCAAGCTTCTCGT 170 
Cyp3a11 TCTCATAAAGCCCTTTCTGA AATGCAGGGTGAAGGAAAGT 103 
Fbp1 TGAGCCTTCTGCGAAGGATG GAAGCAGTTGACACCACAAT 118 
Igfr2 AGAGAGGAAGGAGACAACTG CAAGTAGTAGGTGTACTCGC 117 
Vimentin ACCAGGTCTGTGTCCTCGTC AATAGAGGCTGCGGCTAGTG 154 
Meg3 TCCTCACCTCCAATTTCCCC GAGCGAGAGCCGTTCGATG 71 
Cyclin E GATCGTTACATGGCATCACA AAACTGGTGCAACTTTGGAG 120 
Cyclin B2 GCCAAGAGCCATGTGACTATC CAGAGCTGGTACTTTGGTGTTC 114 





Table A.2: Primer Sequences (Continued) 
p27 CAGAATCATAAGCCCCTGGA GGTCCTCAGAGTTTGCCTGA 190 
Cdk1 GCCAGATAGTGGCCATGAAG TCCATGGACAGGAACTCAAA 178 
Cdk6 AATCTGCTCAACCCATCGAG GTTGGATGGCAGGTGAGAGT 186 
Aqp7 AAGTGTTCAGAGCCGGAAAC GGGTGAATTAAACCCAGGTA 100 
Gapdh AACGACCCCTTCATTGAC TCCACGACATACTCAGCAC 191 
Beta-Actin CCCTAAGGCCAACCGTGAAA CGGAGTCCATCACAATGCCT 134 
Human Primers for qRT-PCR assays   
Gene name Primer Sequence (5'-3')  Amplicon  
 Forward Reverse Size 
CELF1 CAGACGGCTATCAAGGCAAT TGGGCCATTCTCTTCTGTTC 113 
CELF2 CACCAATGCAAACCCTCTCT CGAGAGAGGTCAAGGAGTTCA 119 
ESRP2 CCCTACATGCTCTGCACTGA GGAATTCTCTTCGGAGGTCA 124 
HnRNP A AGGCAGTGGCAAGAAAAGG CAGTTGTGGCCATTCACAGT 105 
HnRNP H AGCTGGCTTTGAGAGGATGA TCTGACCCAAATCCATAGCC 99 
HnRNP L CTGGGGACTCGGATGACTC ACAGGGCCACAAGGATTACA 118 
HnRNP LL GGAGGGGGAGATCGACTACT ACGACGGGTGAAACAGAAAC 150 
MBNL1 CATTTGCAAGCCAAGATCAA AGCAGGCCTCTTTGGTAATG 129 
MBNL2 GCCCAGCAGATGCAATTTAT GGAGCAAAGCTAATAGCCGTA 108 
PTBP1 GTTCGGCACAGTGTTGAAGA CAGCAGGCGTTGTAGATGTT 135 
SRSF1 GCGACATCGACCTCAAGAAT GCAGACGGTACCCATCGTAA 126 
SRSF2 GTCGACCTCCAAGTCCAGAT TTGGATTCCCTCTTGGACAC 129 
Beta-Actin CTGGAACGGTGAAGGTGACA AAGGGACTTCCTGTAACAATGCA 145 






Table A.2: Primer Sequences (Continued) 
TaqMan Probes from Life Technologies   
Gene name Catalogue Number Assay ID Amplicon 
Size 
ESRP1 4351372 Mm01220936_g1 97 
ESRP2 4331182 Mm00616290_m1 68 
Primers for adenovirus cloning   
Gene name Forward Reverse  
ESRP2 gtaactataacggtcATGGATTACAAG
GATGACGATGACAAGACTCCGCC
GCCGCCG 
attacctctttctccCTACAAACACACCCACTCCTTAGGGGC
TTG 
 
 
 
